https://www.cambridge.org/core/terms Downloaded from Proceedings of the Nutrition Society orsodn author: Corresponding Abbreviations: injury against neurons protect neurotoxins brain, to by the a potential induced within exert a to actions proposed including neuroprotective been investi- have of They avidly multiplicity years. been recent of in have class gated flavonoids, a particular termed in beverages, compounds phytochemical and foods Various CVD of of constituents disorders. factors, onset and neurodegenerative lifestyle incidence the important and influence most strongly can the diet of one Representing Society g Nutrition the of Proceedings erigadcgiiefunction cognitive and learning inflammation iae NS nuil Osnhs;JK -u -emnlkns;MP,mtgnatvtdpoenkns;P3,popaiyioio 3-kinase phosphatidylinositol PI3K, kinase; protein mitogen-activated MAPK, kinase; N-terminal c-Jun B. JNK, kinase synthase; protein NO PKB, inducible iNOS, kinase; h uhr21 is ulse nie1 eray2010 February 17 online published First 2010 Author The https://www.cambridge.org/core eodatoiat:teclua n oeua neatosof interactions molecular and cellular the antioxidants: Beyond h umrMeigo h urto oit a eda h nvriyo ury ulfr n3 ue2Jl 2009 July June–2 30 on Guildford Surrey, of University the at held was Society Nutrition the of Meeting Summer The 2 ofrneo Oe-adudrurto:calne n approaches’ and challenges undernutrition: and ‘Over- on Conference aood n o hs nepnteratoso h brain the on actions their underpin these how and flavonoids etefrItgaieNuocec n erdnmc,Uiest fRaig edn G A,UK 6AP, RG2 Reading Reading, of University Neurodynamics, and Neuroscience Integrative for Centre (2) DF ri-eie ertohcfco;CE,cM epneeeetbnigpoen R,etaellrsga-euae protein signal-regulated extracellular ERK, protein; element-binding response cAMP CREB, factor; neurotrophic brain-derived BDNF, n h oeta opooememory, promote to potential the and ihnteetressesaddsrbshwsc neatosaelkl oudri neuro- underlie to likely are interactions such brain how abnormal and flavonoids describes and of species and normal actions effects. neurotoxic stimulatory both systems logical or of scavenge three inhibitory result potential and these the a improve within with explores hippo- as review to react the brain present in directly The the ability ageing. neurogenesis in to an and produced capacity angiogenesis agents through their trigger pro-inflammatory second, to by pro- and third, expression; regulate flow campus; phospha- that blood gene the cerebral pathways and notably and kinase most peripheral factors brain, interactions protein transcription the their mitogen-activated in through survival low and cascades first, signalling processes: their 3-kinase/Akt of glial separate and multiplicity tidylinositol and three this absorption neuronal by Instead, mediated important unlikely. limited underpinned were is with be their explanation actions to by this memory, However, such appears that induced promote flavonoids. suggest effects that injury brain to of thought the against in was potential capacity bioavailability neurons it a antioxidant protect Originally, and the to function. reverse neuroinflammation by potential cognitive suppress or a and to prevent learning including effects ability to these routes, an mediate and of Flavonoids neurotoxins, disorders number performance. neurological cognitive neuro- a the in of via limit deteriorations variety to abnormal suggested or a been normal has with beverages associated and foods degeneration flavonoid-rich of consumption The . https://doi.org/10.1017/S0029665110000054 rJrm .E pne,fax Spencer, E. P. Jeremy Dr 1 (1) oeua urto ru,Sho fCeity odadPamc and Pharmacy and Food Chemistry, of School Group, Nutrition Molecular naiiyt upesneuro- suppress to ability an , . IPaddress: urto oit ivrMdlLecture Medal Silver Society Nutrition (3,4) (2010), 170.106.202.226 hsmlilct of multiplicity This . lvnis erlgclefcs oeua actions Molecular effects: Neurological Flavonoids: 69 4–6 doi:10.1017/S0029665110000054 244–260 , + 4189108,[email protected] email 0080, 931 118 44 eeyP .Spencer E. P. Jeremy , on 25 Sep2021 at12:09:49 rgee ynuooi pce n oapooinof promotion differentiation a to and and apoptosis survival of species inhibition neurotoxic neuronal an to by leading signalling triggered brain neuronal the important in First, with cascades processes. interact three flavonoids by underpinned the be to appears effects eod h aood nueprpea n cerebral and peripheral expression. induce gene mitogen- flavonoids and regulate the factors that and Second, pathways transcription (MAPK) phos- (PI3K)/Akt pro-survival kinase the protein notably 3-kinase activated most cascades, and kinase phatidylinositol signalling protein of kinase number a lipid on actions selective include , subjectto theCambridgeCore termsofuse,available at 1,2 (1) hs effects These . ; https://www.cambridge.org/core/terms Downloaded from Proceedings of the Nutrition Society namtr gnspoue ntebana eutof result a ageing pro- brain as abnormal brain and and the species normal in both neurotoxic produced scavenge agents inflammatory and with directly aclrbodflwi anrta a edt the to growth cell lead nerve may new hippocampus that of the manner and in a angiogenesis in of induction flow blood vascular aoe frrve,seManach iso- see review, anthocyanidins; (for flavanols; flavones; flavones flavonols; flavanonols; subclasses: flavonoids seven molecules flavanones; into glycosylation the divided basic of and/or be the pattern may alkylation of hydroxylation saturation their the the and system, by in ring together variations C; on bound flavan (ring Based heterocycle are two 1). oxygenated which an of Fig. forming B), atoms, consisting All and C seeds. structure three (A grape common rings and a and beans aromatic a of tea cocoa share as as constituents such such flavonoids major beverages seeds are vegetables, and such and wine a fruit as of in and ubiqui- variety found resulting plants pathway are in each Flavonoids the tously flavonoids. branches, of intermediates side class central different several these into C From diverges ring 1). of flavanones position from (Fig. skeleton flavanonols C-3 between the differentiation of allows hydroxylation 2,3-dihydro-2-phenylchromen-4-one the structure, similar fitrflvnclnae C4C6o -–- nthe C2– in structures) additional C-4–C-8 A-type in or with bonds (e.g. (C-4–C-6 series, units linkages positions B-type constitutive the inter-flavanic their and as sequence of of their known basis epicatechin), and the also catechin on oligomers oligomeric differ These and forms proanthocyanidins. or monomers tannins flavan-3-ols, as condensed as to both referred exist sometimes are which flavanols, hloeflvnn smrs h hloepeusris flavanone precursor and a synthase chalcone chalcone into the enzymes isomerised isomerase the flavanone of chalcone malonyl-CoA. action of a the molecules of reaction Under three the with from precursor plants chalcone in synthesised are Flavonoids of impact be the performance. address will cognitive fully human research to on diets of help flavonoid-rich and may areas current that memory this future of highlighted as light potential in such Finally, flavo- information, subjects. outcomes of human in consumption behavioural learning support the and to between data noids to relationship enough attempt is causal also there will a present It at system. whether vascular signalling address and the neuronal neuroinflammation on impact inhibit with their to interact potential flavonoids to their of deterio- pathways, ability mechanisms abnormal will their review neuroprotective or through present normal the The berries, performance. reverse highlight cognitive or as in disorders prevent rations neurological neurodegen- of the to such variety limit a and to with fruits, potential associated a eration flavonoid-rich holds life throughout of sumption h rsneo alcai oeyi - position C-3 in moiety acid gallic and a B ring of of their presence pattern in hydroxylation Variations the the cocoa. in and reside apples structure wine, red teas, black h aaosaefudpeoiatyi re and green in predominantly found are flavanols The https://www.cambridge.org/core lvni:sucsadstructure and sources Flavonoid: (2) . https://doi.org/10.1017/S0029665110000054 hr,teflvnismyreact may flavonoids the Third, . (8) (5,6) . IPaddress: . lhuhte hr a share they Although . tal et O 170.106.202.226 C rC2– or –C7 (3) neatoso aood:nuooia fet 245 effects neurological flavonoids: of Interactions . (7) hs h con- the Thus, . .I addition, In ). , on 25 Sep2021 at12:09:49 O –C5 porrum nlyi el frrve,seWlimo Manach & Williamson and see liver review, the their (for in cells during tract, in gastrointestinal occurs finally the that from conjugation absorption and transformation oxidants a hnudroasrto n r ute metabolised further liver are that and the acids absorption induce in phenolic undergo microflora simple gut then to the may flavonoids of of enzymes breakdown the the which in colon, yigadoiiig n hs I(ojgtn and and (conjugating and de-glucosylated II sulfates are derivatives glucuronides, phase they into metabolised i.e. and (hydro- enzymes, I oxidising) phase detoxifying) for and substrates are lysing polyphenols) other (and Manach tal et oimb atrai h oo a lorsl nthe in result also and groups may bacterial colon several species of the meta- growth their in beneficial that selective bacteria and forms. suggested by been absorption bacterially-derived recently bolism generation, has these it the of Moreover, in bioactivity is there interest potential although date, intense to ignored now largely been has intestine lhuhflvnishv enietfida powerful as identified been have antioxidants flavonoids Although pyran central the 1). of (Fig. level ring oxidation to variability soyabean according structural classified in large found a tomatoes family have and They flavonoid and products. the soya of fruit genistein and and subclass daidzein citrus a as such are in isoflavones Finally, 1). predominantly taxifolin) (Fig. hesperetin, found naringenin, are (e.g. flavanones Dietary (e.g. in flavonols to predominantly the rise found ( are onions gives termed which structure quercetin), flavone also kaempferol, the 3-hydroxyflavones, of 3 the position on lation ( chives ( blue- as such fruits berry ( The and fruits. wine berries berry and and red cyanidin many wine include pelargonidin, and as malvidin red such grapes tea, anthocyanins of apples, cocoa, sources as in such concentration fruits epi- high be at may gallate, which found proanthocyanidins, and epicatechin gallate catechin, gallocatechin include epigallocatechin, centres flavanols two and creates dietary position epicatechin, C 2–3 Typical ring on the asymmetry. group at of 3-OH bond a double of a presence of the lack The 1). (Fig. r on natcoe( artichoke luteolin) apigenin, in and (e.g. number Flavones, found around 1). Individual groups in (Fig. are methoxy rings environment. and variation three hydroxyl their the blue the the or of of from red arrangement pH appear arise and the anthocyanins soluble to water are according plants, in sides ( fruticosus bopin eaoimaddsrbto fflavonoids of distribution and metabolism Absorption, pu graveolens Apium Fragaria , subjectto theCambridgeCore termsofuse,available at . > (15) 0 sflvnshv enietfidt aeadare and date to identified been have isoflavones 600 (19) limschoenoprasum Allium .I h ml netn n ie itr flavonoids dietary liver and intestine small the In ). limcepa Allium L) n rcoi( broccoli and (L.)) tal et acnu corymbosum Vaccinium ,cere ( cherries ), otasrto rmtegsritsia tract gastrointestinal the from absorption Post . · nvivo in (14,16,17) (15,18) ananassa nvitro in . (13) h xeto eaoimi h large the in metabolism of extent The . clet&Williamson & Scalbert , ute eaoimocr nthe in occurs metabolism Further . . n ase ( parsley and L.) slmtdb h xesv bio- extensive the by limited is .,les( leeks L.), .Teecmonseita glyco- as exist compounds These ). (9–11) rnsavium Prunus hi blt oata anti- as act to ability their , yaacardunculus Cynara rsiaoleracea Brassica n te eb.Hydroxy- herbs. other and ) limampeloprasum Allium ,bakere ( blackberries ), erslnmcrispum Petroselinum n strawberries and ) (14) O n Spencer and -methylated i.1). Fig. ; ,celery ), Rubus var. (12) ), , https://www.cambridge.org/core/terms Downloaded from Proceedings of the Nutrition Society 4 .P .Spencer E. P. J. 246 https://www.cambridge.org/core ytae(L) G,eialctci;EG pctci alt;EC,eialctci gallate. epigallocatechin EGCG, flavonol gallate; the (UFGT), epicatechin leucoanthocya- transferase about synthase ECG, 3-O-glucosyl (ANS), epigallocatechin; isoflavone bring glucose-flavonoid synthase EGC, (FSI/FS2), UDP to (FLS). anthocyanidin (ANR), synthase act synthase reductase (DFR), flavone anthocyanidin enzymes reductase three (CHI), (LAR), and Various dihydroflavonol reductase isomerase phenylpropanoid nidin (F3H), (CHS). chalcone from 3-hydroxylase classes: substitution synthase derived the flavanone flavonoid are chalcone and (IFS), that various C by precursors ring the biosynthesised chalcone of of saturation from and formation of derived extent malonyl-CoA are the of flavonoids structure, All ring molecules the position. of C-3 pattern the hydroxylation in the in reside groups vidual 1. Fig. H yiei HOH H OH H OCH OH Isorhamnetin Myricetin H Quercetin Kaempferol Flavonols O H Flavonols derivatives Flavonols Anthocyanidin derivatives Anthocyanidin O pgnnHH H H OH Apigenin Luteolin Flavones h tutrso h ancasso aood n hi isnhss h ao ifrne ewe h indi- the between differences major The biosynthesis. their and flavonoids of classes main the of structures The OH . OH https://doi.org/10.1017/S0029665110000054 UFGT O O O O R R 2 2 . IPaddress: OH 3 R R FSI/FS2 2 3 R H R 2 CoAS 3 FLS hnlrpni Malonyl-CoA Phenylpropanoid R 3 R 170.106.202.226 3 O aignnHO OH OCH OH H H Hesperetin Naringenin aioi HO OH OH OH H O-rhamnosyl OH Engeletin Astilbin Taxifolin Flavanones Flavanonols , on H GGglaeOH OH H gallate gallate OH H H EGCG ECG OH OH EGC Epicatechin Catechin Flavanols H H O O O 25 Sep2021 at12:09:49 R R Condensed tannins Condensed 2 1 (proanthocyanidins) Dihydroflavanol OH R -hmoy HOH OH O-rhamnosyl OH OH 1 CHS and CHI and CHS UFGT F3H O 3 + O O O O R 1 R OH R 1 1 OH R R R , subjectto theCambridgeCore termsofuse,available at 2 2 R 2 4 HO OH R R 3 R 4 3 3 O H R 3 ANR LAR O IFS DFR SCoA H avdnOCH OCH Malvidin Petunidin epiii HOH OCH H H OH OH Peonidin H Delphinidin Cyanidin Pelargonidin Anthocyanidins O H H O O eiti HOH OH Daidzein Genistein Isoflavones Leucoanthocyanidins R 1 OH OH ANS O O O OH O + R HH OH R OH OH 1 1 R R 2 1 3 3 3 R 2 R OCH OH H R 2 OH R R 2 3 2 3 https://www.cambridge.org/core/terms Downloaded from Proceedings of the Nutrition Society ie aebe hw otaes h lo–ri barrier blood–brain the traverse to relevant shown in been pelargonidin-3-gluco- have and side, cyanidin-3-rutinoside cyanins, etta eti rgguuoie a rs h blood– the cross may glucuronides barrier sug- drug brain to certain polar exists that more evidence the gest than However, uptake glucuronides. brain greater flavonoid of capable be may hs nteban aebe trbtdt hi blt to ability their to attributed actions been antioxidant have brain, exert including the flavonoids, on of those actions biological the Historically, direct of capable are and brain actions. that the neuromodulatory suggest and in results neuroprotective brain, localise these the may subjects, to they human bioavailability their in work establish particularly further to Although cerebellum. necessary and is cortex the in found eaoim 3 ojgto ihtil,priual glu- particularly P450-related thiols, with (2) tathione conjugation metabolism; (3) intracellular oxidative of metabolism; types (1) three least metabolism: at undergo also flavonoids their ca fet fflvni metabolites flavonoid of effects ficial atclryi h ri hr hyaefuda nyvery only at found are concentrations they where flavonoids low brain of the antioxidant bioactivity in H-donating the particularly for classical accounts this activity that unlikely highly dnie ndfeetrgoso h riso rats been of brains have the of anthocyanins regions different several in identified Furthermore, tration. ewe aignnadqectnflxit h brain the into flux quercetin situ and naringenin between ri olwn hi nrvnu administration intravenous their following brain are,wihcnrl nr fxnboisit the into xenobiotics of entry blood–brain controls the brain which penetrate additionally barrier, must they directly eaiet hi aetalcns(ride hs on in found those reduced indeed greatly (or aglycones is the plants) parent so in their do to species) to relative nitrogen effectiveness their and particular, circulation, oxygen (in reactions reactive antioxidant scavenging in adducts participate flavonoid–glutathione still may as such metabolites cellular sulfates, glucuronides, nteritrcin ihseiceflxtransporters P-glycopro- efflux as such specific barrier blood–brain with tein the in interactions expressed their mechanism uptake on specific a be glucuronides for may there that suggesting neratv pce rtruhterpsil influences possible their status through redox intracellular or on species reactive enge etain fflvnisadtermtblt om accu- forms metabolite their mulated and flavonoids of centrations lo–ri are eerto sdpneto compound on dependent lipophilicity is penetration barrier blood–brain pgloaehngallate epigallocatechin nins eoddfrsalmlcl nixdn uret uhas such nutrients and acid antioxidant ascorbic small-molecule for recorded leer-e pigs blueberry-fed nodrfrflvnist nunebanfunction brain influence to flavonoids for order In (28) (33) (37,38) (27) nvivo in naiasflvnnshv enfudt ne the enter to found been have flavanones animals In . https://www.cambridge.org/core (21–26) hc per ob epnil o h differences the for responsible be to appears which , (20) lvnnssc shseei,nrnei and naringenin hesperetin, as such Flavanones . nvivo in nixdnso inligmolecules? signalling or Antioxidants r on ntebanatrteroa adminis- oral their after brain the in found are aysuishv niae htalthough that indicated have studies Many . nvitro in (29) . (30) eaoie,aogwt oedeayantho- dietary some with along metabolites, ..ls polar less i.e. , (42) nvivo in n xr hraooia effects pharmacological exert and a (40) -tocopherol r oe hg n (high lower are (1) and . ned ti la httecon- the that clear is it Indeed, . https://doi.org/10.1017/S0029665110000054 iheee natanthocyanins intact eleven with , hi ri nr a lodepend also may entry brain Their . (35) nsitu in O (9) mty eiaie n intra- and derivatives -methyl epicatechin , hog hi blt oscav- to ability their through , (41) . IPaddress: oee,i snwthought now is it However, . (43) models O osqety h bene- the Consequently, . mtyae metabolites -methylated M low , 170.106.202.226 nvivo in (28) (36) neatoso aood:nuooia fet 247 effects neurological flavonoids: of Interactions hi xetof extent Their . m n anthocya- and M r unlikely are hnthose than ) (34) , on nvivo in (39) whilst , 25 Sep2021 at12:09:49 (31,32) and in , , uha sobt,wihaepeeta ihrconcentra- antioxidants higher at out-compete present to are (high which ability tions ascorbate, their as from such result to signalling oi rti c- n o-rncitoa niiinof inhibition non-transcriptional promoter and death Bcl-2 Bcl-xL/Bcl-2-associated protein totic ciaino h APrsos lmn-idn protein element-binding response cAMP (CREB) the of activation emdae yteritrcin ihseicproteins specific with cascades signalling interactions may intracellular flavonoids their to of central by effects cellular mediated the be that suggest to lated yoiekns,poenkns n AKsignalling MAPK and C kinase PI3K/Akt, pathways protein the effects as kinase kinase, such neuronal protein cascades, tyrosine of signalling exert number kinase a lipid to and with interactions shown their been through have Flavonoids progression the on disease. impact brain may chronic they of how and actions such ciaino c-Jun of activation en nldn uB uDadatvtn transcription activating and 2 JunD JunB, factor including teins n poigatos npriua nnuoa apopto- neuronal in particular in actions, sis opposing ing rncitoa ciiisadatvto fdependent of activation and and their proteins of genes activities enhancement cytosolic the of in transcriptional and resulting JNK number factors ERK, a transcription activated Once phosphorylate 2). p38 (Fig. (JNK) cascades kinase p38 mitogenic N-terminal path- and c-Jun (ERK) stress-activated the the kinase and way are protein signal-regulated pathways extracellular MAPK best-characterised nrclua inligptwy ioa ncontrolling potentia- long-term memory in and differentiation, tion pivotal and survival pathways neuronal low neuronal critical (at signalling with actions interactions intracellular neuroprotective their exerting via of shown concentration) signalling been capable have PI3K/Akt be flavonoids example, to the For 2). and (Fig. cascade pathway signalling MAPK IKcsae nterglto fkyfntossc as such formation functions and memory key MAPK and of regulation plasticity utilise the synaptic neurones in cascades post-mitotic regu- PI3K the signalling brain In kinase outgrowth. neurite mature lipid and and synaptogenesis survival, kinase lates system protein nervous during which immature detrimental in the be in inflammation particularly could development, diseases, they neurodegeneration, proliferative and be cancer, may target in cascades kinase of beneficial these at state actions Although neuronal inhibitory expression. phosphorylation selective gene affect modulating the by profoundly and/or altering molecules to by likely function are pathways these iae n lyacnrlrl ntasuigvarious transducing in role responses central intracellular into a signals play extracellular and kinases have the studied. on could disease both and dependent pathways type be cell will these and outcomes within unpredictable interactions vonoid ad N a ensrnl ikdt transcription- to linked strongly been signalling apoptotic has dependent JNK hand, AKbln otespraiyo serine/threonine of superfamily the to belong MAPK (60) , subjectto theCambridgeCore termsofuse,available at (59) R12aeuulyascae ihpro-survival with associated usually are ERK1/2 . ietitrcin ihsgaln pathways signalling with interactions Direct (62,64) R n N r eeal osdrda hav- as considered generally are JNK and ERK . (68) (48–54) (61–63) ayivsiain aeidctdthat indicated have investigations Many . m M Fg ) h prglto fteanti-apop- the of up-regulation the 2), (Fig. Fg ) niioyo tmltr cin at actions stimulatory or Inhibitory 2). (Fig. om to hog ehnssta a involve may that mechanisms through (3,45–47) (67) M .Hwvr vdnehsaccumu- has evidence However, ). n te ciae rti- pro- protein-1 activated other and h rsn eiwwl examine will review present The . (65,66) osbytruhthe through possibly , (62,63) (44) (55,56) nteother the On . uha the as such , (57,58) hsfla- thus , The . https://www.cambridge.org/core/terms Downloaded from Proceedings of the Nutrition Society aood n hi eaoie a neatselectively pathways interact signalling may MAPK the metabolites within their and flavonoids Spencer E. P. J. 248 od nteEKpathway ERK the on noids eitdb neatoswt AKknssMK and receptors MEK1 membrane kinases potentially MAPK and with MEK2 interactions by mediated ioeei,dfeetain ppoi n aiu om of plasticity forms factor-induced cellular various growth and in apoptosis involved differentiation, are mitogenesis, important JNK is and flavonoids ERK1/2 by as signalling MAPK of modulation hraooia ouaoso R inligsc as specific such to signalling (2 homology ERK of PD98059 structural modulators close pharmacological have flavonoids hr smc vdnet upr h cin fflavo- of actions the support to evidence much is There https://www.cambridge.org/core Transcription ciaigtasrpinfco ;MK,JKsrs-ciae rti iaeatvtrmxdlnaekns ;TAK, 3; kinase lineage mixed activator kinase ATF-2, protein 1; JNK/stress-activated kinase factor signal-regulating MLK3, growth wide apoptosis apop- signal transforming a 2; ASK1, STAT, and regulate protein; factor receptor; migration element-binding oestrogen may transcription cell response ER, they entry, activating cAMP p38 transcription; CREB, cycle pathways of and kinase; activator cell these (JNK) MEK and differentiation, MEKK, on kinase transducer proliferation, kinases; effects N-terminal MAPK cell their MKK, c-Jun growth, MEK, Through on cell tosis. neuroprotective. including actions be processes, inhibitory of to whilst variety likely kinase pro-survival, protein also generally signal-regulated are are extracellular of pathways Akt Activation and glia. and 1/2/5 neurons (ERK) in cascades signalling (PI3K)/Akt 3-kinase 2. Fig. A,Blx/c- soitddahpooe;mO,mmaintre frpmcn NS nohla ircoxide nitric endothelial eNOS, rapamycin; of target mammalian mTOR, synthase. promoter; death associated Bcl-xL/Bcl-2 BAD, Intracellular signalling response Biological 0 -amino-3 kinase Stimuli factor (65,66,70–72) oeta onso aoodato ihnmtgnatvtdpoenkns MP)adphosphatidylinositol and (MAPK) kinase protein mitogen-activated within action flavonoid of points Potential . https://doi.org/10.1017/S0029665110000054

0 mtoyaoe.Teflavonol The -methoxyflavone).

. IPaddress: . (53,73,74) CREB, STAT-1,3, Differentiation b Development Growth factors atvtdkns ;PK hshioiiedpnetkns-;PB rti iaeB; kinase protein PKB, kinase-1; phosphoinositide-dependent PDK, 1; kinase -activated A 170.106.202.226 hc pert be to appear which , ER Cell stress MEK1/2/5 ERK1/2/5 MEKK2,3 - Growth Mitogens Raf, c- (52,69)

, Elk h potential The . Raf

(44,52) -1

, on Indeed, . 25 Sep2021 at12:09:49 MEKK1,4 JNK1,2,3 ASK1 MKK4–7 Oxidative stress Differentiation Inflammation c-Jun, ATF-2, Growth factors 53, SMAD4 Apoptosis Cytokines aebe hw oidc ernlaotssvaa JNK than via through rather signalling apoptosis ERK pro-apoptotic neuronal of of induction inhibition induce by the to involving shown mechanism been its have extent lesser a to and quercetin hw osiuaepopoyaino R12adthe and ERK1/2 of phosphorylation stimulate to shown o xml,teflvn3o –-pctci n n of one ERK1/2. and 3 on (–)-epicatechin effect metabolites, flavan-3-ol stimulatory its the a example, have exert flavonoids For to some hand, observed other activa- also the been strong On subsequent caspase-3. is indeed a of Bcl-xL/Bcl-2- tion and and phosphorylation, of promoter death activation activation, (PKB) associated downstream ERK by B accompanied of kinase inhibition Akt/protein potent The , subjectto theCambridgeCore termsofuse,available at MLK3, TAK MKK3–6 p38 0 Omty-–-pctci,hv been have -O-methyl-(–)-epicatechin, Cell cyclecontrol ASK1, p53, eNOS ASK1, p53, Oxidative stress Differentiation BAD, mTOR Apoptosis Cytokines O PKB/Akt Integrins PDK1,2 Growth PI3K mtyae metabolites -methylated (54) . https://www.cambridge.org/core/terms Downloaded from Proceedings of the Nutrition Society niiosaalbe Y902 a oeldo the on modelled was quercetin of LY294002, structure available, inhibitors ontemtasrpinfco RBa physiologically- at concentrations CREB relevant factor transcription downstream h et fseicnuoa ouain r crucial are development populations brain neuronal early specific during of events death the uha h irsflvnn eprtnidc h activation the induce hesperetin flavanone citrus the as such 3 oei tesidcdapoptosis stress-induced essential an in plays also role 1, kinase signal-regulating apoptosis hc ntr ciae N Fg )adide p38 indeed a MKK4, and 2) to activates (Fig. response JNK and in activates stimuli turn activated in stress-related be which of can 1 variety kinase regulating rs N ciiyadaotssidcdb H by induced apoptosis sup- may and quercetin activity and JNK JNK death press cell 6-hydroxydopamine-induced neuronal inhibit and activation to shown been 4-hydroxy-2-nonenal mitochon- the p38 involving pathway and signals death JNK via cell both apoptosis drial of to activation lead the and induce has to 1 shown kinase been signal-regulating apoptosis of Overexpression n RBi o bevdwt (–)-epicatechin-5-O- with observed are con- not pathway is higher this CREB at ERK1/2 and on of apparent stimulation effects Furthermore, longer specific. concentration that no suggesting is centrations, pathway ERK the upr faptn niaottcato fflavonoids of action anti-apoptotic cells potent these in a evidence in compelling of providing support flavonoids, is neurons by in caspase-3 blocked of activation oxidative-induced that E14 hc hshrlt n ciaeMAPK activate activate and JNK phosphorylate kinases and then the kinase which phosphorylate an MKK4–7, MAPK of kinases which typically composed is kinase, MEK1–4, unit kinase signalling core MAPK the MAPK, other h upeso fJKaddwsra atescjnand c-jun partners downstream involving and pro-caspase-3 mechanism JNK a of via suppression the damage oxidative against rons IK ioa iaei ernlsurvival neuronal of in effectors kinase downstream pivotal main a the PI3K, of serine/threonine one the Akt/PKB, through kinase signalling modulate to shown fbt rti iaeCadEK/ activities ERK1/2 and C and kinase restoration protein the toxicity involve both to of shown 6-hydroxydopamine been has deprivation against epigalloca- serum flavanol, gallate, another of techin action protective the tions, a edpneto elo ebaepreblt,a has as reported pathway permeability, previously membrane ERK or been cell the on on dependent be effects may that suggesting glucuronide, ossetwt urei n t eaoie cigat acting metabolites its action activity and PI3K of inhibiting quercetin mechanism and a with by consistent pathways signalling Akt/PKB vivo in aood eemnswehro o hyata potent as act they PI3K not of of structure or the inhibitors whether that determines demonstrated have flavonoids studies of number lvnishv ogbe nw omdlt IK via site PI3K, ATP-binding modulate its to with known interactions been direct long have Flavonoids tml nbt eeomna n eeeaiedahsig- death pro-apoptotic degenerative of and array nalling developmental wide both a in to stimuli response in loss neuronal 0 - nadto oteMP aha aood aebeen have flavonoids pathway MAPK the to addition In hr ssrn vdnelnigteatvto fJKto JNK of activation the linking evidence strong is There O mty-pctci aebe hw opoetneu- protect to shown been have -methyl-epicatechin https://www.cambridge.org/core (65,68,79) eaoie aebe hw oihbtpro-survival inhibit to shown been have metabolites (79,81) (53,86) h ciaino h N aha and pathway JNK the of activation The . (53,73,76,85) Fg ) nte AKkns kinase, kinase MAPK Another 2). (Fig. (50,94) iial,teflvn acli has baicalein flavone the Similarly, . (89) . https://doi.org/10.1017/S0029665110000054 (48,49,95) (75) n ftems eetv PI3K selective most the of One . h aaoseiaehnand epicatechin flavanols The . (80,82) n TNF and (76) neetnl,ti ciainof activation this Interestingly, . (54) nspoto hs observa- these of support In . . IPaddress: urei n oeo its of some and Quercetin . netgto a indicated has Investigation . oee,ohrflavonoids other However, . (82,83) a (69) 170.106.202.226 . ppoi signal- Apoptosis . neatoso aood:nuooia fet 249 effects neurological flavonoids: of Interactions (80) (90–93) swt the with As . (51) (77,78) ned a Indeed, . 2 , on O Fg 2). (Fig. 2 . 25 Sep2021 at12:09:49 (87,88) b (84) - D - , . soitddahpooe,csae9adcsae3in caspase-3 and caspase-9 neurons promoter, proteins cortical pro-apoptotic Bcl-xL/Bcl-2- death 1, of kinase associated signal-regulating inhibition apoptosis the as such and Akt/PKB of Osnhs iO)adN n nrae AP oxi- NADPH increased and NO activation and dase (iNOS) synthase NO AKsgaln acds uha 3 rEK/,which TNF cells ERK1/2, and or iNOS p38 both as regulate such cascades, signalling MAPK opa rca oei h eeomn fAlzheimer’s of development disease the believed Parkinson’s in are and role brain crucial disease a the play in to processes Neuroinflammatory la cells micro- BV-2 glial lipopolysaccharide-stimulated in phorylation rdcini ciae irgi i niiino h JNK the of inhibition pathway via signalling microglia activated in production on thg ocnrtosi irsfut,hsbeen has injury lipopolysacchar- neuronal reducing interferon- fruits, resulting in citrus and effective in highly ide- be concentrations to high found at found aal fpeetn rgesv ernlls ikdto linked loss neuronal progressive neuroinflammation preventing of capable n yoie natvtdmcolaadastrocytes and microglia the activated iNOS in both of cytokines mediates and regulation controlled which post-transcriptional are and signalling, events transcriptional these MAPK of upstream majority by The 3). (Fig. death n pgloaehngallate epigallocatechin and hs fet pert eedo naiiyt directly path- to signalling ability kinase an lipid on and All ways depend kinase generation. protein to species modulate appear activation oxygen effects oxidase reactive these NADPH produc- subsequent (4) NO release; (2) and (1) cytokine expression; microglia: (3) 2 and tion; cyclooxygenase astrocytes and in mechanisms of, iNOS inhibition via include that neuroinflammation astrocyte-mediated cito atr motn niO rncito.Oeof One transcription. iNOS in important tran- factors pro-inflammatory scription downstream influence may kinases tein ae yrdcn namtr nuyi pcfi brain specific in injury inflammatory of regions reducing onset dis- the by Parkinson’s delaying ease, in particularly effective disorders, be neurodegenerative may anti-inflammatory ibuprofen non-steroidal drug the that suggests Evidence enlne oteaottcdaho ern.I particular, (IL-1 In production neurons. cytokine of in have death apoptotic increases that the mediators to other linked been and cytokines release astrocytes leit eriflmaintruhteihbto of NO inhibition partially to the to leading found through been TNF pathways neuroinflammation have inhibiting they alleviate although of structurally- production, to incapable The appear a flavonoids 3). other be and and (Fig. hesperetin transcription-1 expression flavanone related of iNOS activator in reduction and transducer signal irgi cells IL-1 microglia NO, inhibit aoe ooi n bacalein and wogonin flavones soitdwt stroke with associated lvnispeeti leer aeas ensonto shown been also have blueberry in present Flavonoids (108) , subjectto theCambridgeCore termsofuse,available at (101,103) a (45,46) production (102) aealbe hw oatnaemcola and/or microglia- attenuate to shown been all have o xml,te a c yinhibiting by act may they example, For . (109) hs hr sadsr odvlpnwdrugs new develop to desire a is there Thus, . niiino neuroinflammation of Inhibition Fg ) stnihbt 3 AKphos- MAPK p38 inhibits fisetin 3); (Fig. (99) (104) (73) n h aoeltoi niisIL-6 inhibits luteolin flavone the and (103) b (2) (110) . hltteflvnlquercetin flavonol the whilst , l otiuet la-nue neuronal glial-induced to contribute all eety h aaoenaringenin, flavanone the Recently, . n TNF and g . idcdgilcl ciainand activation cell glial -induced h fet fflvniso these on flavonoids of effects The . (98) (103) ciae irgi and/or microglia Activated . (107) a i nihbto fp8and p38 of inhibition an via a xrsini ciae glial activated in expression (106) n h sflvn genis- isoflavone the and (96,97) rdcini activated in production h aaoscatechin flavanols the , b TNF , swl sinjury as well as a ,inducible ), (105) (100,101) the , . https://www.cambridge.org/core/terms Downloaded from Proceedings of the Nutrition Society oiiy nrae nF n/rdpeino endogenous of depletion and/or Fe antioxidants in pro- increases multi-factorial excito- toxicity, by glutamatergic triggered neuroinflammation, including be cesses, to neurodegenerative believed other is and diseases disease, Parkinson’s Alzheimer’s in disease, observed neurodegeneration underlying The aln n sivle niO induction iNOS in involved is NF- and nalling factors, transcription these Spencer E. P. J. 250 oyacaie n interferon- lipo- and in activation protein-1 polysaccharide- able activating naringenin and NF- flavanone transcription-1 the suppress have and with flavonoids to quercetin activation, some factor flavonol nervous notion, transcription the prevent central this to of shown the been support in determining In in response system. tran- production neuroinflammatory pathways, cytokine the signalling and between factors interplay scription is there that cells (103,105) https://www.cambridge.org/core niiino oi-nue ernlinjury neuronal toxin-induced of Inhibition . (112–114) Microglia and/orastrocytes yioio -iae(IK/k,laigt nihbto fnuoa ppoi.SA-,sga rndcrand transducer mitogen-activated MEK1/2, protein. signal element-binding promoter; response death STAT-1, cAMP associated CREB, Bcl-xL/Bcl-2 apoptosis. kinases; BAD, kinase kinase; neuronal protein N-terminal of c-Jun phosphati- JNK, induce inhibition and 1; and kinase 1/2 an species IFN- (ERK) to transcription-1; neurotoxic kinase of leading scavenge protein activator oxide they signal-regulated (PI3K)/Akt, nitric neurons extracellular inducible 3-kinase in In as dylinositol reduction such release. a pathways, oxide to leading signalling nitric cells pro-survival and glia expression pathway reactive p38 (iNOS) related the synthase and inhibit (DHBT-1) Flavonoids dihydrobenzothiazine (ROS). (CysDA), species oxygen 5-S-cysteinyl-dopamine by induced injury neuronal 3. Fig. flavonoids k Inhibition b Inhibition ,sga rndcradatvtrof activator and transducer signal B, . h ellrmcaim ywihflvnisadtermtbltspoetaantnuonamto and neuroinflammation against protect metabolites their and flavonoids which by mechanisms cellular The IFN hr sagoigbd fevidence of body growing a is There . https://doi.org/10.1017/S0029665110000054 γ STAT oxidase NADPH IL CD23 iNOS p38 O y . IPaddress: -1 2 .– β -1 TNF k ,rsod op8sig- p38 to responds B, g atvtdmicroglial -activated 170.106.202.226 α IL-1 TNF ONOO g β NO α interferon- ,

(111) - suggesting , , on 25 Sep2021 at12:09:49 g N,ratv irgnseis S1 ppoi signal-regulating apoptosis ASK1, species; nitrogen reactive RNS, ; Caspase-8 ROS/RNS JNK1/2 ASK1 BAD Bcl - bet oneatti ernlijr,teeydelaying pathologies thereby brain be injury, these may neuronal of polyphenols progression this the other counteract and to flavonoids able that suggest to ethpoaplnuosaantN-and NO- against neurotoxicity neurons induced hippocampal tect methyl-4-phenyl-1,2,3,6-tetrahydropyridine feti euigters fPrisnsdisease beneficial Parkinson’s a of have risk may the tea reducing green in of effect consumption the that pce nnuoslaigt N xdto,caspase-3 oxidation, DNA to leading and neurons oxygen reactive in neurotoxicity intracellular in species strong increase sustained a possess initiate conjugates cholamine xml,a example, gis ipcma nuydrn rnin lblischae- global transient mia during injury hippocampal against oi --ytiy-oaieadisoiainproduct oxidation its neuro- and dihydrobenzothiazine endogenous the 5-S-cysteinyl-dopamine of formation toxin the involve to thought nareetwt h atrsuy e xrcsadpure toxicity attenu- and to extracts 6-hydroxydopamine-induced shown tea been study, ate have latter 3-gallate the (–)-epigallocatechin with agreement In xL , subjectto theCambridgeCore termsofuse,available at h et fnga ern nPrisnsdsaeis disease Parkinson’s in neurons nigral of death The Caspase-9 (126) apoptosis DHBT Neurona Caspase-3 n opeetnga aaeidcdb 1- by induced damage nigral prevent to and ikobiloba Ginkgo ERK1/2 Scavenging b Scavenging -1 Activation by flavonoids by Activation Akt flavonoids Activation; , l CysDA (128,129) (120) CREB n tde aedemonstrated have studies and xrc a ensont pro- to shown been has extract y MEK1/2 Neuron PI3K Fg ) 5-S-cysteinyl-cate- 3). (Fig. inhibition. , (125) (1,46,115–119) (127) oprotect to , . b -amyloid- (121–124) For . . https://www.cambridge.org/core/terms Downloaded from Proceedings of the Nutrition Society yoiaeidcdoiaint il cysteinyl-catechin undergo a yield to catechin by to adducts of oxidation inhibited capacity the tyrosinase-induced is to linked 5-S-cysteinyldopamine mechanism of formation rti iaeCadMP inligpathways signalling MAPK and C kinase, tyrosine kinase kinase PI3K/Akt, lipid the and protein as kinase such protein cascades, of signalling number a modulating by inligptwy n h ciaino caspase-3 of activation the and pathways signalling death neuronal delayed and activation os stogtntt eyo ietrdcl roxidant- or radical- direct on rely this to not activity blocking thought scavenging in is to so potential effective their do although are injury, neuronal flavonoids oxidant-induced that evidence AKkns rMP;()b fetn h ucinof kinase, function kinase the affecting the MAPK by modulating (3) i.e. MAPK; by directly, or (2) ATP kinase kinases to MAPK receptors; binding of by and (1) activity enzymes ways: of cap- on number are a sites pathways they in acting signalling that of with indicates at able evidence interaction activity the unresolved, their be remains Although of pharmacological to factors. site thought transcription exert precise and are kinases to brain receptors, the high reach sufficiently that metabolites their neo h aao ( flavanol the of ence a nii i ietitrcinwt tyrosinase it with interaction that for- direct indicating the via by adducts, inhibit accompanied may cysteinyl-hesperetin not of is hesperetin, mation as such nones, ir fptet ihPrisnsdisease Parkinson’s substantia the with in patients elevated of be to nigra mortem post observed been r aal fpooigbnfiilefcso memory, on effects and performance beneficial fruit- cognitive and promoting that learning of suggest capable to flavonoids, are evidence particular in much phytochemicals, vegetable-derived now is There a against neurons protect insults. to neurotoxic found of been variety anti-apoptotic have potent and their of action, support in evidence MAPK the providing block the to modulating both observed by of expression. been damage activation gene have neuronal by flavonoids oxidative-induced to and/or example, leading activity, molecules, For altering caspase target are by in of function pathways changes state neuronal these phosphorylation affect at the profoundly actions to stimulatory likely or Inhibitory fctci n epicatechin and catechin of urei,hseei,cfecai,4 pelargonidin, con- acid, including caffeic nanomolar hesperetin, flavonoids, by nigral quercetin, various counteracted endogenous of effectively centrations potential is neuro- injury be nal 5-S-cysteinyl-dopamine-induced may However, species toxins. such that dut a egnrtdb eciespecies reactive by generated be may adducts fet ietyo h ri’ naeacietr for architecture innate brain’s the exert to on ability memory their directly through memory on effects impact components to able non-nutrient are low-molecular-weight these that rpsdt lyarl nteptooyo ayneuro- many of pathology the in diseases role a degenerative play to proposed ouaino yatcpatct n neuro-cognitive and plasticity synaptic of Modulation ecieoye n irgnseishv lobeen also have species nitrogen and oxygen Reactive https://www.cambridge.org/core (132) (3,47,142,143) ncnrs,teihbto foddb flava- by afforded inhibition the contrast, In . h ocnrtoso aood and flavonoids of concentrations The . (76,86) . https://doi.org/10.1017/S0029665110000054 (113) performance nta,te r eivdt act to believed are they Instead, . + (130) Fg ) hr sabundant is There 3). (Fig. -aehntyrosinase-induced )-catechin . IPaddress: (53,87–89) utemr,i h pres- the in Furthermore, . (119,133–141) 0 Omty derivatives -O-methyl 170.106.202.226 (128) neatoso aood:nuooia fet 251 effects neurological flavonoids: of Interactions n PI3K/Akt and (131) Fg ) Such 3). (Fig. (130) suggesting , tappears It . (132) , on n have and 25 Sep2021 at12:09:49 (76,86) . (1,46) (73) , . 4 ypeevn Ca preserving kinases; to by opposition in (4) act which phosphatases, important TR amla agto aayi;VEGF- factor rapamycin; growth of thelial target mammalian mTOR, rpi atr r,teatvt-euae cytoskeletal-associated neuro- activity-regulated N-methyl NMDA-R, the brain-derived Arc/Arg3.1; termed Arc, protein kinase; BDNF, cAMP factor; Ca–calmodulin protein; CREB, trophic CaMK, kinase; element-binding respectively; protein response C signal-regulated ultimately extracellular and that protein ERK, B PKC, brain in PKB, A, PKA, the changes cognition. kinase to in and lead learning neurogenesis memory, may influence and processes Such plasticity brain. synaptic the in expression 4. Fig. 1 APdpnetpoenkns ;()PKB/Akt (2) A; kinase 3): protein (Fig. memory cAMP-dependent and (1) plasticity synaptic potentiation, term of con- control acquisition, memory on changes storage. influence morphological and direct induce solidation neu- a to in ability have synthesis an that protein thus new and induce rons to potential the have lsiiyadmmr Fg ) lvnisaenwwell in now plasticity crucial synaptic are pathways signalling inducing Flavonoids neuronal 4). modulate to (Fig. of known memory regions synaptic and promoter re-modelling, synapse plasticity the with to associated genes binds many that factor transcription aood pert neatpiaiywt h ERK the with the primarily pathways increasing interact PKB/Akt in neurons, to and between involved connections appear of, be flavonoids strength to and of, known number are pathways ouaigsgaln acdsligdwsra of to binding downstream and activation sequences lying factor promoter transcription cascades i.e. kinases, signalling modulating ERK Ca 3 rti iaeC 4 acloui kinase Ca–calmodulin (4) C; kinase protein (3) aiu niiulcsae aebe ikdwt this with linked been have cascades individual Various 2 Neuronal communication + , subjectto theCambridgeCore termsofuse,available at BDNF, Nrf,Arc Dendritic spinegrowth (3) Neuronal morphology dpnetatvto fknssi ern;()by (5) neurons; in kinases of activation -dependent lvni-nue ciaino ernlsgaln n gene and signalling neuronal of activation Flavonoid-induced Synaptic plasticity l v ahascneg osga oCE,a CREB, to signal to converge pathways five All . Enhanced memory,learningandcognition enovo de Cell signallingandgeneexpression PKA, PKB/Akt,PKC,CaMK,ERK b TGF- ; rti ytei ntecneto long- of context the in synthesis protein (3,4) Plant bioactives 2 + yafcigsc ahasthey pathways such affecting By . NMDA-R (46,54,75) b CREB rnfriggot factor growth transforming , oesai,teeypreventing thereby homeostasis, (3) n lhuhec fthese of each although and ,

h ciaino these of activation The . New nervecellgrowth Increased bloodflow mTOR, VEGF-B,TGF- Vascular effects Angiogenesis D apraereceptor; -aspartate b aclrendo- vascular ,

b (83) . β (5) ; (81) ; https://www.cambridge.org/core/terms Downloaded from Proceedings of the Nutrition Society 5 .P .Spencer E. P. J. and density learning for spine vital memory be to and neuronal flavo- considered factors through in two mechanism is morphology, about One increases interpreting come may information. for noid-induced provision this sensory structure which memory or efficient by long-term nerve more and potential a afferent the short-term providing have both by will activation enhance acqui- CREB path- to inducing memory to of during leading capable ways required Agents factor consolidation. be of and to neurotrophic sition production known brain-derived and is CREB as (BDNF), activa- factor such the transcription neurotrophins with the along of flavonoids, tion blueberry by pathways 252 ri,a hs gnsmyla oa mrvmn in improvement an to the lead may of may regions that specific agents agents in these memory CREB effective considerable as of to brain, safe activity led the has identifying enhance processes in these in interest CREB of role pcfial lcstefraino ogtr memory long-term of formation the blocks specifically ocnrtoso urei r fetv tenhancing at effective are activation quercetin CREB of concentrations erae nBN n r-DFhv enrpre in reported been have pro-BDNF and BDNF in decreases h nuto fln-atn hne nsnpi plasticity synaptic memory in changes and long-lasting of induction the acloui iae(IadI)o rti iaeA of kinase that protein or than IV) in rather and increases ERK1/2, (II by kinase of mediated Ca–calmodulin state be phosphorylation to shown the been have memory h ciaino R n CREB and on dependent ERK mechanism of a enhance activation by to mice the and in potentiation of recognition long-term object improve efficacy to shown the strength affecting 4). and (Fig. partners, connectivity communication synaptic synaptic neuronal and in experience sensory between alterations altered to as that well paradigms lead with as occur synaptic to shown induce been have motility and hra gnsta nraeteaon ratvt of activity or amount the process the increase accelerate that CREB agents whereas epica- of concentrations in observed low been also to is has techin pathway exposed and ERK neurons the fibroblasts to activate restricted to not ability this Furthermore, neurons the cortical influence in signalling capable to ERK1/2 hesperetin found flavanone activating citrus of been the with also pathway, ERK have flavonoids Other orltswl ihteatvto fCE n with in and levels BDNF CREB mature of and hippocampus pro-BDNF activation the both the in with increases blueberry with well supplemented correlates rats in performance memory ciaini otclnuosadsbeunl increases expression subsequently gene and CREB neurons CREB-regulated and cortical ERK1/2 in both activation induces (–)-epicatechin flavanol hsnuorpi sitmtl ikdt h oto of control the to memory linked long-term and intimately plasticity is synaptic neurotrophin this rtcltasrpinfco ikn h cin fneuro- function differentiation of synaptic survival, actions neuronal and to the BDNF as linking such trophins factor transcription critical yoaietetdadsrmdpie neurons 6-hydro- in serum-deprived activities ERK1/2 and and restoring C xydopamine-treated 3-gallate kinase protein (–)-epigallocatechin both as such flavanols RBatvto ontemo R per rtclin critical appears ERK of downstream activation CREB iei,aflvni on nsrwere,hsbeen has strawberries, in found flavonoid a Fisetin, https://www.cambridge.org/core (147) (152) . eetsuishv hw htspatial that shown have studies Recent . (144) (148–150) (133) hne nsiedniy morphology density, spine in Changes . (54) . https://doi.org/10.1017/S0029665110000054 leer-nue mrvmnsin improvements Blueberry-induced . euaino DFi neetn as interesting is BDNF of Regulation . (153–155) n irpino RBactivity CREB of disruption and . IPaddress: (152) osqety h central the Consequently, . RBi nw ob a be to known is CREB . (75) (145,146) 170.106.202.226 hltnanomolar whilst , (156) iial,the Similarly, . Fg )and 5) (Fig. , on 25 Sep2021 at12:09:49 (73) (77,78) (151) (133) (133) and , . . lhie’ disease Alzheimer’s h aepathways same the naeadters fCD niaigvrospotential various indicating CVD, flavanol of between risk relationship using the inverse epidemio- and an subjects intake substantiated for human data have logical in foods interventions flavanol-containing dietary Recent DFmyrflc ri eeaini epnet aood and flavonoids to of response measures in performance. plasma rel- generation cognitive be Additionally, brain general to reflect cognition. potential may in the BDNF have changes blood–brain generation to the the of cross and evant sites cells) may both glial BDNF (BBB) and As barrier (neurons cells). brain (endothelial the periphery in occur may flavonoids 5. Fig. AKadpoenkns inligptwy,wis its whilst pathways, 4 signalling metabolite A kinase protein and MAPK ernldnrt outgrowth dendrite neuronal r-oano DFi soitdwt eoydefects the subjects memory of human with in 66 function associated hippocampal position abnormal is at and BDNF methionine of for pro-domain valine replaces that yokltlascae rti emdArc/Arg3.1 termed protein cytoskeletal-associated TRptwyadteicesdtasaino specific of translation the increased of fla- the subpopulations activation by mRNA and the Akt tropomyosin triggers pathway of hippocampus mTOR post-synaptic activation the The or in receptor. vonoids pre- B to kinase receptor BDNF of binding transmission oiei apl-ehxltdflvn on ncitrus outgrowth in neurite found induces flavone also poly-methoxylated peel) (a nobiletin etdit ag uhomsae pnstruha polymerisation through actin spines on mushroom-shaped morphological con- dependent are large of spines mechanism small into induction when observed verted that the as such and changes in strength changes facilitate synaptic may expression Arc/Arg3.1 Increased ernlmrhlg cu nrsos oflvni sup- flavonoid to in response changes that in plementation indicated occur have morphology studies neuronal role, this of support n a enpooe ob ne euaoycnrlof control regulatory under be potentiation BDNF to long-term proposed in both been important has be to and known is which of activation the pathway to signalling lead PI3K/Akt to shown the been also has expression fet nteprpea n eervsua system cerebrovascular and peripheral the on Effects , subjectto theCambridgeCore termsofuse,available at lvni-nue ciaino RBadBDNF and CREB of activation Flavonoid-induced eeaino ri-eie ertohcfco BN)by (BDNF) factor neurotrophic brain-derived of Generation Neuron Brain BDNF Cognition (166) (161) 0 (164) dmtynbltneet iia fet via effects similar exerts -demethylnobiletin n htcranflvniscninfluence can flavonoids certain that and i t blt oitrc ietywith directly interact to ability its via Glia n h R signalling ERK the and (167) (157,158) (160) . Flavonoid nldn h activity-regulated the including , BBB utemr,apolymorphism a Furthermore, . nvitro in (133) rsmbyvathe via presumably , Blood BDNF Endothelial cell (165) (78) Furthermore, . (162) n synaptic and Fg 4). (Fig. (163) (133) (159) .In , . https://www.cambridge.org/core/terms Downloaded from Proceedings of the Nutrition Society aao-eitdbociiisicuigteimprovement vasodilatation the of including bioactivities flavanol-mediated ainrsos fcnutatre n naugmented an and arteries of level conduit dila- the of flow-mediated in microcirculation enhanced response elevations an acute tation species, in NO result circulating to shown been n nixdn eec systems defence antioxidant and eoamai otmnpua women post-menopausal in terolaemia nrae nflwmdae iaaini ainswith patients following observed in been also dilatation have disease flow-mediated artery coronary in increases naeo aao-ihfossc sccao fpure of in of markers effective surrogate or function highly and cardiovascular be cocoa flow blood to as peripheral shown improving such been foods has (–)-epicatechin flavanol-rich of intake ac n lcs tolerance glucose and tance aebe bevdatrcnupino flavanol-rich of consumption disease after chocolate artery or observed cocoa coronary been and have diabetes patients hypertension, in species with NO plasma and dilatation flow-mediated nohla yfnto nsmokers in dysfunction endothelial reactivity https://www.cambridge.org/core (175) n h mrvmn fimn responses immune of improvement the and (172,178,179) (168–172) (172,174) . https://doi.org/10.1017/S0029665110000054 Pump r lotogtt lyarl ndtriigbanbodflwadcagsi cognitive in changes and effects flow vascular blood brain Such determining clotting. in role blood a factors and play Blueberry, risk to performance. cardiovascular function of thought vascular number also a are pressure, induce to blood shown been including have particular in Flavanols 6. Fig. Valve (178) lo pressure blood , Gauge Cuff n aao-ihccareverses cocoa flavanol-rich and o xml,icessin increases example, For . blood pressure (174) h naeo aaoshas flavanols of intake The . . IPaddress: h eihrlvsua n adoaclrefcso aoodrc foods. flavonoid-rich of effects cardiovascular and vascular peripheral The h teuto fplatelet of attenuation the , Lower (176,177) (180) 170.106.202.226 Cocoa (181) (173) neatoso aood:nuooia fet 253 effects neurological flavonoids: of Interactions n hypercholes- and Brachial artery Furthermore, . acnu corymbosum Vaccinium Fg ) The 6). (Fig. nui resis- insulin , HO , on Improved vascularfunction Diameter Reduced riskofCVD 25 Sep2021 at12:09:49 OH diameter Resting Flavanols Bluberry Blood velocity O 250 mmHg5min Haemodynamometer osmto fbaktao rp juice grape or tea black of consumption enrpre htflvnl ih ept oe blood lower hypertension to with help subjects might in flavanols pressure that reported been nuneN rdcinadendothelium-dependent and to observed production been relaxation also NO have metab- flavones influence and flavanol flavonols specific olites, monomers, flavanols actions flavanol of such absorption), forms oligomeric exert production. that NO may unlikely and is synthase it NO acti- Although, endothelial direct the a of via vation dilatation endothelium-dependent induce nohla Osynthase on directly NO actions increase through to endothelial flavonoids perhaps of levels, ability NO an circulating by mediated are effects xeiet aeidctdta oo flavanols cocoa that indicated have experiments nbanbodflw hr seiec osgetthat suggest to evidence is There flow. depend also blood to parti- known in brain are brain, which on the cognition, in on effects effects cular flavonoid determining in role elh individuals healthy rp-eie polyphenols grape-derived . hypermia Reactive hsaiiyt fetvsua ucinmyas lya play also may function vascular affect to ability This OH , subjectto theCambridgeCore termsofuse,available at diameter Dilation R 1 nvivo in R R 3 Tea 2 (178,191–193) (174) blood clotting Decreased thsbe rpsdta these that proposed been has It . nvivo in (168,186–188) (189,190) . bcueo hi poor their of (because aeteaiiyto ability the have Indeed, . (182,183) (173,184,185) thsalso has It . (186) nvitro in n in and and https://www.cambridge.org/core/terms Downloaded from Proceedings of the Nutrition Society 5 .P .Spencer E. P. J. growth vascular memory to influence may response near and in clustered factors are proliferate cells vessels, hippocampal blood new Indeed, 4). (Fig. stroke cere- with dementia of associated forms and those many including preventing disease, of brovascular capable are flavonoids 254 aebe hw oiflec eervsua blood cerebrovascular influence to shown flow been have in otoe ie evn h ytmls fceti the information. in sensory efficient less of system storage the and connec- leaving processing synaptic time, deteriorate or over to rel- lost populations known tions neuronal is particularly with structure is aging, brain neuronal with innate which against this ageing, as brain evant with the associated protect inter- the losses Furthermore, also for for memory. interactions and of structure such retrieval information efficient and sensory processing more or cellular storage, a nerve the afferent with pro- preting consequently brain in and the changes cognition vide for beneficial perfusion. required induce blood architecture cerebral effects an an and signalling and to Such peripheral differentiation cell leading of and survival periphery, enhancement the with species, neuronal the neurotoxic of interact by cere- and promotion triggered to apoptosis brain improve of the inhibition ability under- to in be an to cascades ability appear by effects an These pinned by flow. and induced blood brovascular activate injury signalling to a against potential synaptic a including neurons neuroinflammation, brain, and to the protect neurotoxins within appear to effects cognition of on potential number flavonoids a dietary involve of actions The ofcltt dl ergnssi h hippocampus the in known neurogenesis is adult function facilitate cerebrovascular to increased as important fe h osmto fflvnlrc oo sn trans- using cocoa reported ultrasound flavanol-rich been Doppler of has cranial blood consumption artery cerebral the cerebral in middle after increase the an through findings, flow these of support In nraecrba lo o for spin- flow flavanols arterial cocoa blood that level-dependent cerebral Furthermore, a indicates increase also with switching. oxygenation MRI along sequence task flow labelling brain, to the the of response regions of certain modification in in increase flow oxygen- an shows blood blood MRI the functional drink level-dependent cocoa ation flavanol-rich a of sumption ihsvrlsuisidctn htteei eraein decrease a dementia is with patients there in that flow blood function, indicating cerebral brain studies optimal for several vital with is flow blood cerebral cient aal fidcn nrae eerlbodflwin flow blood intervention cerebral post are h increased 1–2 flavonoids subjects inducing earlier, human to of mentioned likely less As capable are dementia. flow blood develop cerebral without higher subjects with with contrast, associated In dementia also Alzheimer’s dementia. is of with flow markers patients blood incipient cerebral in low lower and is disease velocity flow blood orlto ewe eerlbodflwadcognitive a and subjects is flow there human blood trans- that in and cerebral shown function MRI between have functional ultrasound correlation as Doppler such cranial techniques imaging (196,197) https://www.cambridge.org/core rsn n uueperspectives future and Present n hs aclrefcsaepotentially are effects vascular these and (194,195) . https://doi.org/10.1017/S0029665110000054 lvnis npriua flavanols, particular in Flavonoids, . (196) . IPaddress: (201) . o xml,cerebral example, For . £ (199) otingestion post h 2 170.106.202.226 utemr,effi- Furthermore, . (196,197) (200,201) fe con- After . , on 25 Sep2021 at12:09:49 (143,198) Brain . (202) . e nge atrdniyadt imreso erlstem neural H of using biomarkers cells to chan- progenitor and with and density compared matter a grey further in hae- as be ges blood such may functioning in addition, changes In changes cognitive modynamic supplementation. assess flavonoid improved Functional of to underlie result techniques. used flow that be MRI blood flow may brain functional measures cell in and MRI stem alterations MRI neural and in hippo- using cells changes in progenitor density, changes and and to volume to responses in advantageous campal behavioural highly effects be of link would evidence it directly example, hard For provide ulti- brain. to the will required assessments be quantitative mately function, dynamic animals assessing and and of structural way subjects appropriate human an cog- in provides appropriate Whilst testing outcomes. behavioural clinical more nitive rigorous more relationships materials, and such in better- controls utilise intervention identify to outcomes required to be characterised will behavioural order studies con- intervention In and future the no between subjects. flavonoids are relationship human there causal of present a questions at of sumption of notably, support number Most in a resolved. data deterio- are be age-dependent there to reverse function, still brain even in or rations limit to potential hudntb goe.Dmni ot nteU alone UK the in costs Dementia ignored. be not should respond also foods. they flavonoid-rich whether with and intervention and BDNF to subjects human cognitive of of in biomarkers usefulness changes as future components the Thus, brain-derived 5). may investigate other (Fig. BDNF plasma should brain in biomarker in studies a increases as that detected and be subjects human in nraei eae oa mrvmn nsailworking spatial in improvement this an and to brain memory related rat in is expression increase BDNF increase to reported h rtcinadrpi fnuosi h eta nervous central the in both neurons in of critical system be repair prevention to and the known protection are for the they targets as decline useful cognitive represent of BDNF as inducing such in doses? effective which beneficial in most maximum and are gain changes these to flavonoids required as which such is intake effects, to frame relating also time factors may other what it dynamic assess approach mechanistic, to an possible a such be Taking in flavo- way. function between quantitative brain and links and provide intake to noid essential be will approach are n hslvl ntepam a eetlvl in blood–brain levels reflect the may cross plasma bio- to the functional in brain shown levels the such been thus has and one barrier it be cognitive as human biochemical may of markers, of surrogates BDNF lack as in used a performance. be performance is can cognitive that there behav- markers determine presently highly-specific subjects, to Although human exist 5). tests or BDNF brain (Fig. ioural induce the periphery either to in ability the production their neurotrophin improvements by other induce mediated and/or to is flavonoids cognition of in ability the whether ensont orlt ihhmnlann,mmr and memory learning, function human with cognitive correlate to shown been , subjectto theCambridgeCore termsofuse,available at oee,atog aoodcnupinmyhv the have may consumption flavonoid although However, ial,teptnilipc fde nhatcr costs healthcare on diet of impact potential the Finally, utemr,temdlto fnuorpi factors neurotrophic of modulation the Furthermore, (203,204) (133) (208) hr sapsiiiyta h aemyoccur may same the that possibility a is there , Fg ) sflvni osmto a been has consumption flavonoid As 5). (Fig. o xml,lvl fbanBN have BDNF brain of levels example, For . (205–207) uueefrssol ou on focus should efforts Future . 1 NRsetocp.Sc an Such spectroscopy. -NMR nvivo in https://www.cambridge.org/core/terms Downloaded from Proceedings of the Nutrition Society aebe siae ob £17 be to estimated been have US n h U(P LVOA.Teauthor The FLAVIOLA). (FP7 (FLA- interest. EU of Agency conflict the no Standards declares and Food the VURS) BB/G005702/1), BB/E023185/ Biological and (BB/F008953/1; 1; Biotechnology Council the Research by Sciences funded is author The new a of development the future for the drugs. flavonoids, memory-enhancing precursors in of fruit-derived that as generation particular possibility act strong in might chil- a of and nutrients, is adults capable specific in there drugs both and of learning, dren, development and the memory enhancing in interest intense mareti le niiul yol %pryear population per ageing long-term the the 1% in for increases only cognitive costs estimated by severe all care out reduce individuals cancel would older would that in treatment impairment a of ment 4 cletA&Wlimo 20)Deayintake Dietary (2000) G Williamson & A Scalbert 14. C Morand G, Williamson and C, Bioavailability Manach (2005) 13. C Manach & G Williamson 12. 1 ieEasC(95 ln oyhnl:fe aia sca- radical free polyphenols: Plant (1995) C Rice-Evans 11. 0 ieEasC(01 lvni antioxidants. Flavonoid (2001) C Rice-Evans 10. .Mnc ,Sabr ,Mrn C Morand A, Scalbert C, Manach 7. colorful A biosynthesis. Flavonoid (2001) B Winkel-Shirley 6. isoflavonoids and Flavonoids (1999) CL Steele & RA Dixon Flavonoids 5. (2009) C Rendeiro & D Vauzour JPE, Spencer 4. .Rc-vn A ilrN aag 19)Structure- more (1996) G are Paganga & NJ foods Miller CA, in Rice-Evans 9. Polyphenols (2005) V Cheynier 8. memory: on flavonoids of impact Neuro- The (2009) (2007) JPE JP Spencer Spencer 3. & D Vauzour K, func- brain Vafeiadou of 2. modulators Flavonoids: (2008) JPE Spencer 1. 2085S. n iaalblt fpolyphenols. of bioavailability and 230S–242S. 93 of Review II. humans. in studies. intervention polyphenols of bioefficacy 61 antioxidants? chain-breaking or vengers viaiiyadbofcc fplpeosi uas I. humans. studies. in bioavailability polyphenols 97 of of Review bioefficacy and availability Chem oe o eeis iceity elbooy n bio- and biology, cell biochemistry, technology. genetics, for model engineering. metabolic for mine 4 gold a – their underlying mechanisms effects. behavioural molecular The cognition: and nixdn ciiyrltosiso aood n phenolic and flavonoids acids. of relationships activity antioxidant thought. 223S–229S. often than complex bioavailability. 747. and sources food considerations. 38 molecular and physiological flavonoids. by Targets Drug modulation Disord Immune its Metab and inflammation tion? 394–400. , https://www.cambridge.org/core 103–116. , 1152–1161. , rJNutr J Br reRdcBo Med Biol Radic Free 8 797–807. , ln Physiol Plant Acknowledgements 99 . up.1 ES60–ES77. 1, Suppl. E , https://doi.org/10.1017/S0029665110000054 rhBohmBiophys Biochem Arch References mJCi Nutr Clin J Am 126 . IPaddress: 20 485–493. , mJCi Nutr Clin J Am 933–956. , · 10 mJCi Nutr Clin J Am tal. et 9 170.106.202.226 (209) 81 7 Nutr J e er Develop- year. per 211–224. , mJCi Nutr Clin J Am neatoso aood:nuooia fet 255 effects neurological flavonoids: of Interactions 243S–255S. , 20)Polyphenols: (2004) ice o Symp Soc Biochem tal. et lo hr is there Also, . rnsPatSci Plant Trends 492 hmScRev Soc Chem 130 20)Bio- (2005) 1–9. , 81 urMed Curr , on 2073S– , 79 Suppl., , Endocr 25 Sep2021 at12:09:49 727– , 81 , 3 i H&Ymzk 20)Rl fPgyorti in P-glycoprotein of Role (2003) M Yamazaki & JH Lin 33. 2 ree K&KozU(92 lcrndto fdrugs. of Glucuronidation (1992) U Klotz & HK Kroemer of role 32. The (1997) HK Kroemer & JT Backman B, Sperker 31. G Kuhnle MS, Dobbie KA, Youdim 29. and interactions Astrocyte-endothelial (2002) NJ Abbott 27. 8 odmK,Qie Z elyDJ Begley MZ, Qaiser KA, Youdim 28. T Tsushida JH, Moon N, Yamamoto 25. 0 amnsa A oln ale E(95 Dis- (1995) RE Paulsen & J Morland TA, Aasmundstad 30. 6 aSlaE,PsuaM,Ymmt N Yamamoto MK, Piskula EL, Silva da 26. T Tsushida JH, Moon M, Shirai 24. M Shirai S, Yamaguchi J, Terao 23. 1 pne P,ShotrH rstwih AJ Crossthwaithe H, Schroeter JPE, Spencer 21. 0 pne P,Khl G ilasRJ Williams GG, Kuhnle JPE, Spencer 20. 2 iaeY hmiK uaaaS Kumazawa K, Shimoi Y, Miyake 22. 9 zui ,VlvcJ uneGG Kuhnle J, Vulevic X, Tzounis 19. heterocyclic oxygen of Metabolism (1999) RR Scheline 18. R Choudhury G, Chowrimootoo JPE, Spencer 16. AM Minihane MM, Mohsen El Abd JPE, Spencer 15. 7 pne P 20)Mtbls ftaflvnisin flavonoids tea of Metabolism (2003) JPE Spencer 17. , subjectto theCambridgeCore termsofuse,available at hraoieis lnclimplications. kinet clinical pharmacokinetics: 292–310. eeauto ftepamclgclsgicneo the of factors. significance modulating pharmacological and the conjugates of re-evaluation A in targeting drug and humans. disposition drug in beta-glucuronidase permeability. barrier blood-brain h lo-ri are naae reymvn asinves- rats sampling. microdialysis Ther moving vivo freely across in awake, by morphine tigated in and barrier blood-brain 6-glucuronide the morphine of tribution vitro in barrier: blood-brain the studies. blood-brain and flavonoids the between tion of model situ in barrier. an across permeability per- plasma. lipid rat ion-induced in copper oxidation inhibit metabolites low- Quercetin human in peroxidation lipid lipoprotein. derivatives density ion-induced related their copper and on metabolites quercetin of effect uoie nlpdprxdto nlpsmlmembranes. liposomal Chem in Food peroxidation Agric 3-O-beta-D-glu- J lipid quercetin on metabolite, quercetin curonide, a of effect ellrmtbls n iatvt fqectnadits and quercetin of metabolites. bioactivity vivo and in metabolism cellular irt-nue nixdn osmto nhmnplasma human in lipoprotein. low-density consumption peroxy- antioxidant of nitrite-induced 3-O-beta-D-glucuronide quercetin and quercetin rats. eriocitrin-treated in of metabolites Chem urine flavonoid of and activity plasma antioxidant and cation 1146. fibroblasts. death and cell neurons peroxide-induced O-methyla- hydrogen in on and epicatechin glucuronidation of tion of influences Contrasting ooe-nue hne otehmnfea microflora. faecal Nutr human J the Br to changes monomer-induced rs,Inc. Press, Compounds Plant compounds. 3261S. h atonetnltract. glucuronidate gastrointestinal and the absorb both can flavonoids. intestine luminal small The 20)Boakr fteitk fdeaypolyphenols: research. dietary nutrition Nutr in of J application Br intake and the limitations strengths, of Biomarkers (2008) 275 42 48 reRdcBo Med Biol Radic Free 59–98. , Neurochem J 3217–3224. , lnPharmacokinet Clin 435–441. , 99 99 R adoko amla eaoimof Metabolism Mammalian of Handbook CRC 782–792. , 22;Eulcto uut2007. August 1 Epublication 12–22; , p 4–9.Bc ao,F:CRC FL: Raton, Boca 243–295. pp. , ESLett FEBS rhBohmBiophys Biochem Arch ice J Biochem 49 85 5602–5608. , reRdcRes Radic Free ESLett FEBS 180–192. , reRdcBo Med Biol Radic Free Nutr J 33 36 458 372 18–31. , 592–604. , tal. et Anat J 224–230. , tal. et 173–181. , 430 lnPharmacokinet Clin tal. et tal. et tal. et 133 tal. et tal. et 20)Poeto by Protection (2001) 405–408. , tal. et 200 35 up. 3255S– Suppl., , 20)Inhibitory (2001) hrao Exp Pharmacol J 20)Flavonoid (2004) 19)Inhibitory (1999) lnPharmaco- Clin 925–931. , 20)Flavanol (2008) 372 20)Identifi- (2000) 629–638. , 20)Interac- (2003) gi Food Agric J tal. et 20)Intra- (2003) tal. et tal. et 347–354. , 31 1139– , (1998) (2001) (1999) tal. et 23 , https://www.cambridge.org/core/terms Downloaded from Proceedings of the Nutrition Society 5 .P .Spencer E. P. J. 256 4 egH,CegF,HagYT Huang FC, Cheng HW, Peng 34. 0 gloG ae-arsr ,MnniS Manenti L, Gamet-Payrastre G, Agullo 50. KY Hui WF, Matter CJ, Vlahos 49. 1 ae-arsr ,MnniS rtcpMP Gratacap S, Manenti L, Gamet-Payrastre 51. 2 ogA,Y ,Ce C Chen R, Yu AN, Kong 52. 5 uauaM kb ,OiaaM Oniyama S, Okabe M, Suganuma 35. 6 b lMhe M uneG ehe AR Rechner G, Kuhnle MM, Mohsen El Abd 36. 8 atrW,BonR lhsC 19)Teinhibition The (1992) CJ Vlahos & RF Brown WF, Matter 48. O Texier C, Felgines S, Talavera 38. G Kuhnle J, Marks MM, Mohsen El Abd 37. 1 olr E uneG,VuorD Vauzour GG, Kuhnle SE, Pollard 41. JE McDonald JB, Blumberg W, Kalt 40. A Vanzo U, Vrhovsek S, Passamonti 39. 7 pne P 20)Fo o huh:terl fdietary of role the flavonoids thought: for of Food (2008) interactions JPE Spencer The 47. (2007) JPE Spencer 46. 2 b lMhe M uneG ehe AR Rechner G, Kuhnle MM, Mohsen El Abd 42. 5 ilasR,SecrJE&Rc-vn 20)Flavo- (2004) C Rice-Evans & JPE Spencer RJ, Williams 45. JPE Spencer C, Boyd gastro- H, The Schroeter (2000) 44. M Whiteman & K Zhao B, Halliwell 43. https://www.cambridge.org/core niio fpopaiyioio -iae 2-(4-morpholi- Chem 3-kinase, (LY294002). phosphatidylinositol nyl)-8-phenyl-4H-1-benzopyran-4-one of inhibitor aeptwy nhmottcrsos n nuto of induction and response cas- and homeostatic MAPK apoptosis. in of role pathways products: pase natural by elicited events a lsaadbantsu yhg-efrac liquid in high-performance conjugate by tissue glucuronide 369–374. brain its and chromatography. and plasma naringenin rat of nation iaeadpoenkns inhibition. tyrosine C 53 kinase with protein comparison and of kinase inhibition a and 3-kinase: structure phosphatidylinositol flavonoid between Relationship analogs. Commun and Res quercetin Biophys by Biochem 3-kinase phosphatidylinositol of rats. to administration Nutr oral J following metabolites pelargonidin its of excretion and and distribution tissue Absorption, 1702. lvnisadteihbto fPCadP 3-kinase. PI and PKC of Pharmacol inhibition the and Flavonoids rvnietaplpeo,i os tissue. cancer mouse a 19 in polyphenol, gallate, tea [H-3](-)-epigallocatechin preventive of distribution paeadmtbls feiaehnadisacs othe to access ingestion. its oral and after epicatechin brain of metabolism and Uptake aood nehnighmnmmr,lann and learning memory, human performance. enhancing neuro-cognitive in flavonoids pathways. signalling 273. neuronal within area, digestive to distribution brain. their and and kidney, rats in metabolism ecino aoodmtbltswt peroxynitrite. Commun with Res metabolites Biophys chem flavonoid of blue- reaction of brain and eye, liver, the pigs. in berry-fed anthocyanins of cation brain. the to pigments grape Chem some of access od:atoiat rsgaln molecules? signalling Med or Biol antioxidants noids: action? antioxidant of site major Res Radic a tract: intestinal 1702. paeadmtbls feiaehnadisacs othe to access ingestion. its oral and after epicatechin brain of metabolism and Uptake fnti oxide. and nitric flavonoids of of influences neurodegeneration: in signaling 1649–1657. , 1771–1776. , 269 53 95 7029–7034. , 51–58. , 36 5241–5248. , rhPamRes Pharm Arch 33 32 838–849. , 819–830. , 279–286. , gi odChem Food Agric J erbo Aging Neurobiol . https://doi.org/10.1017/S0029665110000054 hoaorBBoe c Appl Sci Biomed B Chromatogr J gi odChem Food Agric J . IPaddress: reRdcBo Med Biol Radic Free reRdcBo Med Biol Radic Free tal. et 23 350 rcNt Soc Nutr Proc 1–16. , 186 960–968. , 20)Sga transduction Signal (2000) 23 tal. et 170.106.202.226 tal. et 861–880. , 624–631. , 56 tal. et tal. et tal. et 705–712. , ice Pharmacol Biochem 53 20)Anthocyanin (2005) tal. et e Nutr Gen tal. et tal. et 19)Aspecific A (1994) 3902–3908. , 19)Determi- (1998) 20)Identifi- (2008) Carcinogenesis 20)MAPK (2002) 67 tal. et gi Food Agric J tal. et 19)Wide (1998) tal. et tal. et tal. et , on 20)Fast (2005) 238–252. , reRadic Free 20)The (2006) 33 33 25 Sep2021 at12:09:49 2 1693– , 1693– , 257– , (1997) (2006) (1999) (2002) (2002) Biol J Free 714 Bio- Gen Br , 3 azu ,VfiduK ieEasC Rice-Evans K, Vafeiadou D, Vauzour 73. 2 atgeV atciM eer K Lefevre M, Gautschi V, Castagne 72. 1 atgeV&Cak G(99 niioso mitogen- of Inhibitors (1999) PG Clarke & V Castagne 71. 0 edgnT kn arM(97 h -u tran- c-Jun The (1997) M Bahr & P Skene T, Herdegen 70. CK Sen S, Roy H, Kobuchi 69. 8 ai J(00 inltasuto yteJKgopof group JNK the by transduction Signal (2000) RJ Davis 68. 7 ern ,SblaM&Wge F(99 Amino-terminal nervous (1999) EF the Wagner & in M Apoptosis Sibilia A, (2000) Behrens BA 67. Yankner & J Yuan 66. 5 ileK&Hree 20)JKadp8stresskinases p38 and JNK (2000) T Herdegen & K Mielke 65. Hydrogen (2002) RJ Williams & S Hasan AJ, Crossthwaite trans- 64. signal Neurotrophin (2000) FD Miller & DR Kaplan 63. AE West A, Brunet A, Bonni 62. 1 nesnC okvk M(99 oefrMAPK/ for role A (1999) AM Tolkovsky & CN Anderson 61. 0 i ,DcesM aneu J Raingeaud M, Dickens Z, Xia 60. 9 ai 19)Terglto fA- ciiyb mito- by activity AP-1 of regulation The (1995) M Karin 59. 7 obM odmt J(95 o A iae are kinases MAP How (1995) EJ Goldsmith & MH Cobb 57. 8 odmt J&Cb H(94 rti kinases. Protein (1994) MH Cobb & EJ Goldsmith 58. 6 watJ 20)Mmr ehnss h i n agof yang and yin the mechanisms: Memory (2001) JD Sweatt 56. 5 i H e H i CH Lin SH, Yeh CH, Lin 55. 3 cree ,SecrJE ieEasC Rice-Evans JPE, Spencer H, Schroeter 53. 4 pne P,Rc-vn ilasR 20)Modu- (2003) RJ Williams & C Rice-Evans JPE, Spencer 54. , subjectto theCambridgeCore termsofuse,available at neleteat-ppoi fet fflvnnsi cortical in flavanones of pathways effects neurons. signaling anti-apoptotic ERK1/2 the and underlie Akt pro-survival of vation system. nervous status. redox developing 59 cellular the the on and Focus death neuronal between ships ciae rti iae rtc xtmzddeveloping axotomized protect kinases neurons. protein activated nuil CM1epeso nhmnedteilcells endothelial pathway. human JNK in the through expression ICAM-1 inducible cito atr–bptnilmdao fnuoa death, neuronal of mediator regeneration. bipotential and survival – factor scription A kinases. MAP n ellrproliferation. apoptosis cellular stress-induced and regulates c-Jun of phosphorylation system. PI3-kinase. eeeaieefcoso inltasuto-acdsin system. signal-transduction-cascades nervous of the effectors degenerative – Ca(2 on dependence neurones: Akt/PKB cortical in ERK1/2, JNK of and phosphorylation peroxide-mediated system. nervous 381–391. the in duction rmtdb h a-AKsgaigptwyb tran- by pathway mechanisms. 286 signaling -independent Ras-MAPK and scription-dependent the by promoted a by against arabinoside. apoptosis protection cytosine of induction survival: JNK-independent neuron p53-dependent, sympathetic in apoptosis. ERK on kinases MAP JNK-p38 and Science ERK of effects 16486. e-ciae rti kinases. protein gen-activated pnSrc Biol Struct Opin regulated. rti phosphorylation. protein iaesgaigptwyi ercniinn n synaptic and amygdala. conditioning the fear in plasticity in pathway signaling kinase 34793. acdsb urei n t nvv eaoie underlie signalling metabolites vivo viability. ERK1/2 in neuronal on its and action and their Akt/PKB quercetin by pro-survival cascades of lation 557. iae(N) -u n caspase-3. and low-density- N-terminal c-Jun c-Jun oxidized (JNK), involving kinase from apoptosis neurons lipoprotein-induced protect Flavonoids 397–423. , 1358–1362. , Nature 270 Neurochem J ri Res Brain ilChem Biol J Neurochem J 1326–1331. , Cell 407 4 833–840. , 802–809. , 103 842 rgNeurobiol Prog Neurosci J 103 239–252. , 215–219. , 270 urBiol Curr 80 a Genet Nat rnsNeurosci Trends 1355–1367. , tal. et mJPhysiol J Am Neuron 14843–14846. , 24–35. , tal. et ilChem Biol J tal. et 20)Arl o h PI-3 the for role A (2001) 19 urOi Neurobiol Opin Curr ilChem Biol J 19)Qectninhibits Quercetin (1999) 31 tal. et 11 664–673. , 61 tal. et 21 ice J Biochem 841–851. , R391–R394. , 19)Cl survival Cell (1999) 45–60. , 326–329. , tal. et 277 19)Opposing (1995) 19)Relation- (1999) rgNeurobiol Prog 20 C403–C411. , tal. et 227–231. , 270 20)Acti- (2007) 278 358 16483– , 34783– , Science + 547– , (2001) and ) Curr 10 , https://www.cambridge.org/core/terms Downloaded from Proceedings of the Nutrition Society 1 ofrP,JnJ&Wogt R(98 rti iaeB kinase Protein (1998) JR Woodgett & J Jin PJ, Coffer 91. 0 end G anrA,Cne SD Conzen AJ, Wagner SG, Kennedy 90. 9 ciaK hrih ,NioY Naito M, Shiraishi K, Uchida 89. 8 siaaY&Ktmr 20)At-ppoi fetof effect Anti-apoptotic (2000) M Kitamura & Y Ishikawa 88. 2 cioH ihd ,Ii K Irie E, Nishida H, Ichijo 82. 7 agL assiaK rk I Araki K, Matsushita L, Wang 87. 5 cree ,Wlim J ai R Matin RJ, Williams H, Schroeter 85. D Jannuzzi K, Diener XS, Wang 83. MAP stress-activated to receptors From (1999) H Ichijo 81. 6 pne P,ShotrH uneG Kuhnle H, Schroeter JPE, Spencer 86. 4 lrn ,Gri ,Iat E Itarte L, Garcia F, Llorens 74. 4 aszw cioH(01 oeua ehnssof mechanisms Molecular (2001) H Ichijo & A Matsuzawa 84. JNK of functions Diverse (1999) D Bohmann & S Leppa 80. AJ Crossthwaithe H, Schroeter JPE, Spencer 76. JPE Spencer P, Bahia H, Schroeter 75. 9 ai J(99 inltasuto ytecJnN-term- c-Jun the by transduction Signal (1999) RJ Davis 79. MB Youdim T, Amit Y, Levites 77. 8 encek ,Ai ,Yui MB Youdim T, Amit L, Reznichenko 78. cAt:amliucinlmdao fphosphatidylinositol of activation. mediator 3-kinase multifunctional a (c-Akt): -iaeAtsgaigptwydlvr nanti-apoptotic an delivers signal. pathway signaling 3-kinase/Akt 2242. tessgaigptwy yteedpouto lipid of product end of production. inducer the peroxide potential intracellular a by is 4-hydroxy-2-nonenal pathways peroxidation. signaling stress urei:itreto nteJK n ERK-mediated and JNK- the pathways. in apoptotic intervention quercetin: yrgnprxd ntekde uueeihla cells epithelial tubule kidney the by E). in induced (NRK-52. apoptosis peroxide ameliorates hydrogen kinase N-terminal c-Jun 500. AKJKadp8sgaigpathways. signaling p38 activates 90–94. that and MAPKKK mammalian SAPK/JNK a ASK1, by apoptosis kinases. et novn aps- activation. caspase-3 cell involving oxidative-stress-induced death from fibroblasts human protect foiie o-est lipoprotein. 29 uptake low-density following oxidized death of cell neuronal attenuate antioxidants apoptosis 1. of 130 kinase regulation signal-regulating death: apoptosis and by life between decision the protein kinase. mitogen-activated kinase to a kinase with homologous kinase protein domain novel catalytic a of characterization and cloning apoptosis. and response stress in c-Jun Oncogene and signaling cortical in GLUR2 upregulates response and AMP neurons. cyclic activity ERK-dependent element differentiation. stimulates full techin induce to unable are Lett in FEBS but activation cells ERK1/2 PC12 EGF-stimulated prolong LY294002 ehnadisi iomtblt,3 metabolite, vivo in its and techin nlkinase. inal fibroblasts. 1146. death and cell neurons peroxide-induced O-methyla- hydrogen in on and epicatechin glucuronidation of tion of influences Contrasting errsu fln-emsrmdpie C2clsand induces cells PC12 outgrowth. serum-deprived (-)-epigallocatechin-3-gallate neurite promotes long-term of polyphenol neurorescue tea cycle cell 3-gallate (-)-epigallocatechin survival/ action. polyphenol cell neuroprotective tea and green activation in C genes kinase protein of https://www.cambridge.org/core 1222–1233. , 1–8. , ee Dev Genes Oncogene Neurochem J 18 510 ice o Symp Soc Biochem 6158–6162. , Nephron 149–153. , . https://doi.org/10.1017/S0029665110000054 11 18 ice J Biochem inyInt Kidney 701–713. , 6087–6093. , ilChem Biol J 101 ilChem Biol J 91 142–147. , 1596–1606. , . IPaddress: reRdBo Med Biol Rad Free Neurochem J 335 tal. et tal. et 58 64 tal. et tal. et tal. et 1078–1087. , 1–12. , ilChem Biol J 271 1–13. , tal. et 0 tal. et Omty epicatechin, -O-methyl 170.106.202.226 277 tal. et reRdcBo Med Biol Radic Free ice J Biochem 20)Aiei and Apigenin (2002) 19)Idcinof Induction (1997) 31607–31611. , 19)Atvto of Activation (1999) tal. et tal. et 20)Ihbto of Inhibition (2002) neatoso aood:nuooia fet 257 effects neurological flavonoids: of Interactions 20)Involvement (2002) tal. et 30574–30580. , ice (Tokyo) Biochem J 19)Molecular (1996) 20)(-)-Epica- (2007) 93 20)Phenolic (2000) 19)TePI The (1997) 1157–1167. , 20)Epica- (2001) Science 20)Green (2005) tal. et 274 31 , on 354 1139– , 2234– , 25 Sep2021 at12:09:49 (2001) 493– , 275 , 0.Aa ,Ahm M ha N Ahmad VM, Adhami F, Afaq 108. 0.LeH i O i H Kim YO, Kim H, Lee 106. 0.L ,HagY,Fn D Fang YG, Huang R, Li 107. LC Pei-Dawn FM, Ho JC, Chen 105. effects Inhibitory (2007) JA Joseph & DF Bielinski FC, Lau 104. HY Lee D, Vauzour K, Vafeiadou 103. 0.Mru S aaktuS,FeglMA Fleegal SL, Karackattu JS, Marcus 100. 0.Ba R hn ,LeJC Lee P, Zhang NR, Bhat 101. 0.Cse ,Yprav ,Rme N Rempel U, Yaparpalvi D, Casper 102. 9 ouaN tfs ,Kd Y Kudo R, Itofusa N, molecular Stroke: Kozuka (2003) 99. MA Yenari & JE Lee Z, Zheng 98. 6 ishE,HntS&Hrmn 20)Neuro- processes Inflammatory (2005) (2003) PL A McGeer & Hartmann EG McGeer & 97. S Hunot EC, Hirsch 96. 5 akrE,Pcl E eii O Perisic ME, Pacold EH, Walker 95. 4 eroaP,Cd ideo r(99 Protein (1989) Jr E Middleton & V Cody PC, Ferriola 94. 3 rwe J&FemnR 19)Phosphatidylinositol (1998) RS Freeman & RJ Crowder 93. 2 ilrF alnD 20)Nuorpi signalling Neurotrophin (2001) DR Kaplan & FD Miller 92. , subjectto theCambridgeCore termsofuse,available at 1035–1044. nnra ua pdra eaioye ygentea green by keratinocytes (-)-epigallocatechin-3-gallate. epidermal kappaB human constituent factor normal nuclear of in activation B-mediated ultraviolet egcnuoa injury. dopami- neuronal inflammation-mediated nergic against protects acti- and microglial vation lipopolysaccharide-induced inhibits gallate rmmdcnlhr snuortcieb inhibiting by neuroprotective is microglia. 1944. of herb activation inflammatory medicinal in from induction oxygenase-1 the and heme by microglia. B on BV-2 mediated factor-kappa mouse depends nuclear is and kinase, quercetin STAT1, IkappaB by of expression inhibition gene iNOS inflammatory of microglia. production Res BV2 Neurosci the J lipopolysaccharide-activated on in extract mediators blueberry of injury. neuroinflammatory against in Biophys protects Biochem signalling Arch and inflammatory cells inhibits glial naringenin flavanone kinase protein mitogen-activated Erk of NF-kappaB. expression and role synthase astroglia: oxide in nitric inducible kine-stimulated rtcsdpmnri ern gis ltmt toxicity glutamate against vitro. in neurons dopaminergic protects srct ttst nuenti xd production. oxide nitric Res induce rosci to different states require cytokines astrocyte proinflammatory and saccharide treatment. for targets Med potential and mechanisms ciae rti iae euaeidcbenti oxide 1633–1641. cultures. in nitric glial expression mitogen- primary gene inducible factor-alpha endotoxin-stimulated of necrosis regulate tumor subgroups and kinases synthase p38 protein and activated kinase signal-regulated Psychiatry disease. Alzheimer’s in Disord disease. Relat Parkinson’s ism in processes inflammatory 1617–1624. otann Y902 urei,mrctn n staur- and by myricetin, inhibition quercetin, osporine. 3-kinase LY294002, phosphoinositide wortmannin, of determinants iaeCihbto ypatflvnis iei mechanisms relationships. Kinetic structure-activity flavonoids. and plant by inhibition C kinase o h uvvlo ev rwhfco-eedn sym- factor-dependent growth nerve of neurons. sufficient survival pathetic and necessary the are kinase for protein Akt and 3-kinase ahasrgltn ernlapoptosis. 58 neuronal regulating pathways 1045–1053. , 3 361–372. , ersiLett Neurosci o Cell Mol 82 27 717–728. , 741–749. , 85 Glia Neurosci J 11 1010–1017. , 6 up.1 S9–S15. 1, Suppl. , 909–919. , 41 289 ersiRes Neurosci J 484 u Pharmacol J Eur 152–160. , rgNuoscohrao Biol Neuropsychopharmacol Prog tal. et tal. et 201–204. , 100–109. , 18 2933–2943. , tal. et 20)(-)-Epigallocatechin (2004) 20)Faoodwogonin Flavonoid (2003) tal. et tal. et tal. et ice Pharmacol Biochem tal. et tal. et tal. et 19)Extracellular (1998) AE J FASEB 78 20)Ihbto of Inhibition (2003) 20)Ihbto of Inhibition (2005) tal. et elMlLf Sci Life Mol Cell 20)Lipopoly- (2005) 723–731. , 20)Tecitrus The (2009) 521 20)Structural (2000) 20)Ibuprofen (2000) Oncogene Neurosci J 9–20. , 20)Cyto- (2003) Parkinson- 17 urMol Curr 1943– , Neu- J 22 18 38 , , , https://www.cambridge.org/core/terms Downloaded from Proceedings of the Nutrition Society 5 .P .Spencer E. P. J. 258 1.Ba R enti L hnQ Shen DL, Feinstein NR, Bhat 111. reduces Luteolin (2008) RW Johnson & KW Kelley S, Jang 110. BM Kwon J, Ock LT, Zheng 109. 2.LeS u i 20)Poetv fet ftegreen the of effects Protective (2000) S Kim & S Suh S, Lee 126. 2.Mne A mtT ene O Weinreb T, Amit SA, Mandel 121. 1.Bria eae 20)Mlclrmechanisms Molecular (2003) E Melamed & A Barzilai 112. 2.LvtsY odmM,Mo G Maor MB, Youdim Y, Levites 125. L Kalfon T, Amit SA, Mandel 122. E Head G, Cole J, Joseph 119. 2.Mne A vaoihTrs ,RzihnoL Reznichenko Y, Avramovich-Tirosh SA, Mandel 124. tea Green (2007) SA Mandel & MB Youdim L, Kalfon 123. V Paramasivam JV, Smith Y, Luo 120. A Rodriguez-Mateos K, Vafeiadou polyphenols: D, Vauzour Catechin 118. (2004) MB Youdim & S Mandel 117. E Head G, Cole J, Joseph neuro- 115. and neuro- nurture Nature, in (2005) AJ mechanisms Hannan & death TL Spires Cell 114. (2001) KA Jellinger 113. 1.WirbO mtT adlS Mandel T, Amit O, Weinreb 116. https://www.cambridge.org/core lto n ciaino AP-1. phosphor- of JNK 105 inhibiting activation by and microglia ylation in production IL-6 neurotoxicity. and lipopolysaccharide-induced pharmacol on activation fisetin microglial flavonoid of effects aplnuoa aaeatrtasetgoa shmain ischemia global hippo- transient after gerbils. against damage gallate neuronal campal (-)-epigallocatechin polyphenol tea 21–29. activating and nuclear protein, factors, factor-2. element-binding transcription protein-beta, nuclear response of cAMP CCAAT/enhancer-binding Roles B, cells. kappa factor glial nitric-oxide in inducible synthase of activation transcriptional mediated hn:aptnilnuortciesrtg o Alzheimer cate- for tea strategy diseases. green neuroprotective Parkinson by and potential targets a brain chins: multiple of manipulation 12197–12202. fslciedpmnri ernldahi Parkinson’s in death neuronal dopaminergic disease. selective of apB(Fkpa)atvto n eldahb tea by death cultures. cell neuronal and in activation extracts factor- (NF-kappaB) nuclear kappaB (6-OHDA)-induced 6-hydroxydopamine pathway. of signaling PKC iron- and genes, stress Neurosignals survival in oxidative cell catechins dependent tea of green Modulation of neuroprotection. activities Multifunctional (2005) epigallo- to reference special (EGCG). polyphenols: gallate activity tea catechin neurorestorative green the in of chelation iron and pathways the by EGb761. activation extract caspase-3 biloba Ginkgo and aggregation amyloid-beta neurodegeneration. and aging, multiplicity a flavonoids: effects. of of potential neuroprotective The a:ipiain o neuroprotection. of 992–1002. for degradation implications proteasome-mediated and Bad: C- kinase rapid protein the promotes (-)-epigallocatechin-3-gallate polyphenol neurodegenera- in diseases. tive neuroprotection and and chelating neurodegeneration iron antioxidant, its properties. of neuritogenic a outcome (-)-epigallocatechin-3-gallate: reflective of mechanisms molecular neurodegeneration. and aging, neurodegenerative in disease. interactions gene-environment logy: degeneration. 7534–7539. , ersiLett Neurosci rnsMlMed Mol Trends ESJ FEBS ee Nutr Genes 8 484–494. , 14 reRdcBo Med Biol Radic Free elMlMed Mol Cell J . 46–60. , https://doi.org/10.1017/S0029665110000054 272 2347–2361. , 287 ilChem Biol J 3 115–126. , ee Nutr Genes N ersiTher Neurosci CNS . IPaddress: 9 191–194. , lhiesDis Alzheimers J 126–132. , tal. et tal. et Neurosci J Neurosci J 5 tal. et rcNt cdSiUSA Sci Acad Natl Proc 1–17. , tal. et tal. et tal. et rcNt cdSiUSA Sci Acad Natl Proc ice Pharmacol Biochem tal. et tal. et tal. et 170.106.202.226 277 37 20)Ntiin brain Nutrition, (2009) 20)Ntiin brain Nutrition, (2009) 4 20)Neuroprotective (2009) 283–296. , 20)Cl signaling Cell (2008) 304–317. , 20)Simultaneous (2008) 29584–29592. , 20)p8MAPK- p38 (2002) 20)Suppressive (2008) 20)Ihbto of Inhibition (2002) Neurochem J 20)Attenuation (2002) 29 29 15 12795–12801. , 12795–12801. , 14 n Immuno- Int 211–222. , 352–365. , , on tal. et 25 Sep2021 at12:09:49 (2008) tal. et 100 63 99 , , , 4.Hri M&KtrS 19)Dnrtcsie:cellular spines: Dendritic (1994) SB hippo- Kater adult & on KM diet of Harris Impact 144. (2009) S Thuret & D Stangl multiple 143. health: brain and Flavonoids (2009) JPE Spencer 142. poly- Fruit (2007) FC Lau & B Shukitt-Hale JA, Joseph 139. 3.Jsp A hkt-aeB&CsdssG(05 Reversing (2005) G Casadesus & B Shukitt-Hale JA, Joseph 138. 4.SuitHl ,CryA io L Simon A, fruit Carey Berry B, (2008) Shukitt-Hale JA 141. Joseph & FC Lau B, Shukitt-Hale 140. 3.SecrJE enrP ailSE Daniel P, Jenner JPE, Spencer 131. K Vafeiadou G, Ravaioli D, Vauzour 130. 3.Jsp A eioaN,Aeds G Arendash NA, Denisova JA, Joseph 137. NA Denisova B, Shukitt-Hale JA, Joseph 136. NA Denisova B, Shukitt-Hale JA, Joseph 135. JA Ellia OB, Kennedy AL, Macready 134. D Vauzour MA, Mohsen El CM, Williams 133. of Inhibition (2007) JP Spencer & K Vafeiadou D, Vauzour 132. 2.Hsig G(95 nyai xdto fdpmn:the dopamine: of oxidation Enzymatic (1995) TG Hastings P 129. Jenner M, Whiteman JPE, Spencer 128. G Maor O, Weinreb Y, Levites 127. , subjectto theCambridgeCore termsofuse,available at pcaiain matn ohsaiiyadflxblt to flexibility and stability function. both synaptic imparting specializations neurogenesis. campal in 243–250. mechanisms. common deficits by underpinned motor effects and cognitive on juice aging. grape Concord behavior and signaling senescence. neuronal in on effects their and phenols reac- Parkinson’s involving in species. formation oxygen GSH of tive and mechanisms possible cysteine disease: with catecholamines of Parkinson’s for polyphenols. Implications by phys protection DHBT-1: and 5-S-cysteinyl- disease neurotoxins and the of dopamine formation induced nitrite n eair eeca rpriso ri polyphenolic fruit of properties communication beneficial compounds. neuronal behavior: on aging and of effects deleterious the model. disease prevents Alzheimer and an Neurosci in signaling deficits enhances behavioral supplementation berry upeetto n h gn brain. aging 56 the and supplementation 924. in neurons. increases cell in and activity modification induce caspase-3 base DNA catecholamines extensive damage, of 5-S-Cysteinyl-conjugates uto,cgiie n oo eairldfiiswith deficits supplementation. behavioral dietary Neurosci strawberry J motor or trans- spinach, and signal blueberry, neuronal cognitive, in declines duction, age-related deficits. of Reversals neuronal behavioral age-related cognitive of Neurosci J and sup- onset E the vitamin signal-transduction or retards spinach, plementation strawberry, dietary for Long-term recommendations rando- and human studies of studies. review trial future A controlled function: mized cognitive and noids levels. (BDNF) Med Biol factor Radic memory neurotrophic Free phosphoryla- brain-derived working CREB and hippocampal tion spatial in changes with in correlate changes Blueberry-induced by 5-S-cysteinyl-dopamine neurotoxin polyphenols. the of formation the oeo rsalni synthase. H prostaglandin of role neurodegeneration. N- minergic dopa- prevents (-)-epigallocatechin-3-gallate methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced polyphenol tea 636–641. , 476 Nutrition 145–151. , 6 153–162. , 19 18 mJCi Nutr Clin J Am ice ipy e Commun Res Biophys Biochem 8114–8121. , 8047–8055. , ee Nutr Genes n cdSci Acad Y N Ann 22 nuRvNeurosci Rev Annu 295–302. , Neurochem J 45 ee Nutr Genes 295–305. , 4 227–242. , 81 Neurochem J Neurochem J up. 313S–316S. Suppl., , 1100 4 71 tal. et 271–282. , Neurochem J tal. et 2112–2122. , tal. et tal. et 17 470–485. , gi odChem Food Agric J tal. et rhBohmBio- Biochem Arch tal. et 341–371. , 19)Conjugates (1998) 20)Efcsof Effects (2006) 78 81 20)Peroxy- (2008) tal. et 362 20)Green (2001) 1073–1082. , 20)Flavo- (2009) ee Nutr Genes tal. et al. et tal. et 20)Blue- (2003) 122–129. , 340–346. , 64 919– , (2002) (2008) (1999) (1998) Nutr 4 , https://www.cambridge.org/core/terms Downloaded from Proceedings of the Nutrition Society 6.Lfr L aaaaK afanWE Kaufmann K, Yamagata GL, Lyford 163. 6.WleetR amranB uf P Wulff B, Dammermann R, Waltereit 162. R Scott R, Bourtchouladze T, Tully 152. 5.Fnbie ,Tvzi F aoasyA Maloratsky SF, Tavazoie S, to Finkbeiner signals neurotrophin 155. couples CREB (2000) S Finkbeiner 154. K Obrietan DM, Smith S, Impey 149. 6.YnY dla M&VnekihP 20)Tebrain- The (2002) PW Vanderklish & GM Edelman Y, Yin 161. 5.Ea F oiaM alct JH Callicott M, Kojima Pro-brain-derived MF, Egan (2003) 159. M Fahnestock & B Michalski 158. EJ Mufson J, Wuu in S, function Peng BDNF 157. (2005) E Messaoudi & CR Bramham 156. L Flechner E, Guzman MD, Conkright 153. J Blendy B, Frenguelli R, Bourtchuladze 151. EC Villacres M, Mark S, Impey 150. DR Storm S, Impey TA, Pham 148. Modulation (2006) JPE Spencer & M Whiteman SE, Pollard 147. involved pathways multiple of Modulation (2009) P Maher 146. 6.ShatG,Ng A hnWG Chen EA, Nigh GM, Schratt 160. fisetin Flavonoid (2006) K Abe & T Akaishi P, Maher 145. rwhfco n ciiyrgltdgn,ecdsanovel a encodes gene, activity-regulated and factor growth a 5484–5493. rti iaeAadmtgnatvtdpoenkinase/ protein activation. mitogen-activated kinase and regulated A extracellular kinase Ca2 protein by induction mRNA Arg3.1/Arc 2373. enhancers. memory for Discov pathway CREB the ertohcfco r erae ntepeciia stages pre-clinical the disease. in Alzheimer’s decreased of brain-derived are mature factor and neurotrophic factor neurotrophic brain-derived re- neurotrophin neuronal of mediator major sponses. a CREB: messages. survival core a reveals responsiveness. genes cAMP 11 target for CREB requirement promoter of analysis ome-wide protein. element-binding mu- targeted cAMP-responsive a the with Cell mice of in tation memory long-term Deficient transcription (CRE)-mediated learning. element contextual during response cAMP of during period. plasticity critical neuronal developmental neocortical the in transcription gene eie ertohcfco nacssnhsso r in Arc of synthesis enhances synaptoneurosomes. factor neurotrophic derived rapamycin-phosphatidylinositol by mRNAs development. Neurosci of neuronal of J during group target pathway select 3-kinase-dependent mammalian a of a translation the regulates fBN n ua eoyadhpoaplfunction. hippocampal and memory human Cell and BDNF of secretion activity-dependent affects polymorphism Alz- val66met in cortex parietal in disease. decreased heimer’s is factor neurotrophic hypoth- consolidation synaptic esis. the plasticity: synaptic adult hippocampus. generate the that of CA1 stimuli 16 area in by LTP expression long-lasting gene CRE-mediated ERK of modulation and a scavenging hesperetin: signalling. intracellular by for injury role fibroblast peroxynitrite-induced by of aging during function neuronal of fisetin. maintenance the in 16573. rmtsEKdpnetln-emptnito and potentiation long-term memory. enhances ERK-dependent promotes https://www.cambridge.org/core 1101–1108. , 973–982. , 79 112 rgNeurobiol Prog 59–68. , ee Nutr Genes 2 257–269. , 267–277. , Neuron ice ipy e Commun Res Biophys Biochem 24 7366–7377. , 19 . ri e o ri Res Brain Mol Res Brain https://doi.org/10.1017/S0029665110000054 Neuron 1031–1047. , 4 rcNt cdSiUSA Sci Acad Natl Proc 297–307. , rcNt cdSiUSA Sci Acad Natl Proc 76 99–125. , Neurochem J . IPaddress: 25 a Neurosci Nat tal. et 11–14. , tal. et tal. et 20)Peusrfr of form Precursor (2005) Neuron tal. et tal. et tal. et 170.106.202.226 + 19)CRE-mediated (1999) tal. et 93 neatoso aood:nuooia fet 259 effects neurological flavonoids: of Interactions 19)Idcinof Induction (1996) n APrequires cAMP and 1412–1421. , 19)Stimulation (1998) tal. et 20)TeBDNF The (2003) 1 tal. et 22 20)Targeting (2003) 595–601. , 347 Neurosci J 111 63–72. , 20)BDNF (2004) a e Drug Rev Nat tal. et tal. et tal. et 916–923. , 103 20)Gen- (2003) 148–154. , 19)Arc, (1995) 99 , on o Cell Mol 16568– , 2368– , Neuron 25 Sep2021 at12:09:49 (2001) (1997) (1994) 21 , 6.A ai . aaiaA ags D Saigusa A, Nakajima M., Rahim Al 167. 8.Wn-oart F ilbac C oart JA Polagruto AC, Villablanca JF, Wang-Polagruto 181. 6.MtuaiK iaaiK aa S Sakai K, Miyazaki K K, Matsuzaki Matsuzaki 166. T, Yamakuni H, Nagase 165. 7.Fse D&Hlebr K(06 gn n vascular and Aging (2006) NK Hollenberg & ND Fisher 179. 8.HisC libnadP ea A Dejam P, Kleinbongard C, Heiss 180. 6.vnPagH ueoM,YoGW Yeo MJ, Lucero H, Praag van 164. 7.ShotrH es ,Ble J Balzer C, Heiss H, Schroeter 178. PI Oteiza RR, Holt CL, Keen 177. C CL Heiss T, Schewe Keen H, Sies DD, 176. Schramm RR, Holt 175. 7.Gas ,LpiC eoin S Necozione C, Lippi D, Grassi 174. R Roesen R, Berkels D, Taubert P 173. Kleinbongard A, Dejam C, Heiss 172. 6.Hrt ,SiaaK aaaeH Watanabe K, Shimada K, Hirata 169. M Gerhard-Herman M, Hughes ND, Fisher 168. 7.SenJ,Kei G ib DA Wiebe JG, Keevil JH, Stein 171. M Blom M, Ericson I, Janszky 170. , subjectto theCambridgeCore termsofuse,available at ehns fnuorpi cino oiei nP1.D PC12. in nobiletin of action cells. neurotrophic of Mechanism 4 to response hippocampus. 194–200. receptor murine postsynaptic in the receptor glutamate AMPA and the GluR1, of subunit, protein phosphorylation augments A-mediated action, kinase neurotrophic with flavonoid citrus 20)Crnccnupino aao-ihcocoa flavanol-rich cell vascular of decreases and function consumption endothelial improves Chronic (2006) 1276–1283. 5878. epne oflvnlrc cocoa. flavanol-rich to responses 1024–1029. osmto fflvnlrc oo n h eeslof reversal the and smokers. in cocoa dysfunction flavanol-rich endothelial of consumption 1580. eeto fsailmmr nmice. in and memory angiogenesis spatial of enhances retention (-)epicatechin flavanol derived neuronal in enriched dendrites. is that protein cytoskeleton-associated eitsbnfiilefcso aao-ihccao vas- on humans. cocoa in flavanol-rich function of cular effects beneficial mediates systolic isolated with individuals elderly hypertension. in pressure blood flavan-3-ols. in rich cocoa of effects xdnsadcrivsua health. 298S–303S. Suppl., cardiovascular and oxidants 304S–312S. mediators. inflammatory and function. platelet 2212–2213. and consumption Chocolate nraei nui estvt n eraei lo pres- blood in persons. decrease healthy a in and significant sure sensitivity a insulin by in followed is increase chocolate dark of administration 1050–1055. h ucpiiiyo D hlseo ooiainin oxidation disease. to artery reduces cholesterol coronary and LDL with function of patients endothelial susceptibility improves the juice grape women in disease. variability heart rate coronary heart with increased with associated male is healthy in reserve velocity subjects. flow coronary increases vaso- humans. healthy nitric-oxide-dependent in induces dilation cocoa Flavanol-rich 7721. maretascae ihND eetrantagonism cascade. receptor ERK the learning NMDA of stimulation with rescues via associated signaling, impairment PKA/ERK/CREB enhancing 0 Dmtynbltn iatv eaoieo nobiletin of metabolite bioactive a -Demethylnobiletin, Biochemistry mJCardiol J Am Neuron JAMA 14 44 433–445. , 290 13683–13691. , 93 mJCi Nutr Clin J Am 1029–1030. , 1384–1388. , tal. et rcNt cdSiUSA Sci Acad Natl Proc Hypertens J Heart mJCi Nutr Clin J Am tal. et tal. et tal. et tal. et 20)Ccapolyphenols Cocoa (2005) tal. et tal. et 91 Hypertens J Biochemistry JAMA u Pharmacol J Eur tal. et mCl Cardiol Coll Am J tal. et 20)(-)-Epicatechin (2006) tal. et 314–318. , 20)Wn drinking Wine (2005) Neurosci J mJCi Nutr Clin J Am 20)Cooaeand Chocolate (2003) tal. et tal. et 20)Ccaanti- Cocoa (2005) 20)Nbltn a Nobiletin, (2008) 81 21 20)Short-term (2005) Circulation 20)Baktea Black (2004) 290 611–614. , 2281–2286. , 20)Vascular (2003) tal. et tal. et 19)Purple (1999) tal. et 20)Acute (2005) 20)Plant- (2007) tal. et 1030–1031. , JAMA 81 24 27 48 Suppl., , 1575– , 5869– , 7713– , (2005) (2009) (2002) (2003) tal. et 578 103 287 100 46 81 , , , , , , https://www.cambridge.org/core/terms Downloaded from Proceedings of the Nutrition Society 6 .P .Spencer E. P. J. 260 8.LietJ,Rte R ulrC Muller TR, Rathel JF, Leikert Effects 187. (2000) CT Kappagoda & K McCormick M, Karim 186. C Lippi S, Necozione D, cocoa Grassi of 185. Effect (2007) E Schomig & R Roesen D, Taubert 184. 9.CmegsD cttV eadS Renaud V, Scotet D, Commenges 194. of Modulation (2007) MR Mustafa & FI Achike M, Ajay 193. AM Mustafa FI, Achike M, Ajay 192. Endo- (1993) RG Coffey & SL Hirschfield DF, Fitzpatrick 189. P Wohlfart TR, Rathel JF, Leikert 188. M Holbrook Jr, JF Keaney SJ, Duffy 183. DA Wiebe JG, Keevil JH, Stein 182. 9.SefnY ugT lt LO Klotz T, Jung Y, Steffen 191. M Karim MT, Galloway MB, Cishek 190. https://www.cambridge.org/core deinmlcl nhprhlseoei postmenopausal women. hypercholesterolemic in molecule adhesion fqectno mardratvt fspontaneously ascorbic of with reactivity study comparative impaired acid. aortae: rat on hypertensive quercetin of fluorescent the of endo- concentrations from low released 4,5-diaminofluorescein. oxide using probe nitric cells of thelial measurement vitro relaxation. in endothelium-dependent on Nutr extracts J cocoa of endo- improves and sion hypertensives. resistance in vasodilation insulin thelium-dependent and pressure meta-analysis. blood a pressure: blood on Med Intern intake tea and disease. artery endothelial coronary reverses lation with consumption patients in tea dysfunction black long-term patients and in oxidation disease. to the artery cholesterol coronary reduces with and LDL function of endothelial susceptibility improves juice grape aood n iko dementia. 363. of risk and flavonoids flavonoid. rat non-antioxidant 385–391. diabetic a and by hypertensive normal, aortae in reactivity vascular (-)-epicatechin. by protection Med Biol cells: (LDL) Radic lipoprotein endothelial low-density oxidized in by elicited fication other and wine products. of grape activity vasorelaxing thelium-dependent endo- synthase from oxide release oxide cells. nitric nitric thelial subsequent endothelial and expression enhance polyphenols e ieo nohlu-eedn eaaini rabbits. in relaxation (Lond) endothelium-dependent Sci Clin on wine red 46 lnEpPamclPhysiol Pharmacol Exp Clin 104 130 398–405. , adoacPharmacol Cardiovasc J 151–156. , up. 2105S–2108S. Suppl., , 167 Circulation 626–634. , . mJPhysiol J Am 93 42 https://doi.org/10.1017/S0029665110000054 507–511. , 955–970. , . IPaddress: 106 1614–1617. , Circulation 265 ESLett FEBS tal. et tal. et u Epidemiol J Eur tal. et H774–H778. , 47 170.106.202.226 33 tal. et tal. et up.2 S177–S186. 2, Suppl. , tal. et 345–350. , tal. et tal. et 20)Ccareduces Cocoa (2005) 20)Poenmodi- Protein (2007) 20)Drc effects Direct (2006) tal. et hrao Res Pharmacol 506 100 20)Rdwine Red (2002) 20)Itk of Intake (2000) 20)Reliable (2001) 19)Efc of Effect (1997) 19)Purple (1999) 131–134. , 1050–1055. , 20)Short- (2001) , on Hyperten- 25 Sep2021 at12:09:49 16 Circu- 357– , Arch Free 55 , 0.AzemrsRsac rs 20)Dmni statistics. Dementia (2009) Trust Research Alzheimer’s 209. 0.SiiuE ahmt ,OauaN Okamura K, Hashimoto E, Shimizu 208. 0.LseC tasyE eh T Leyhe E, Stransky C, Laske 207. T Leyhe E, Stransky C, Laske 206. GW Eschweiler E, Stransky C, Laske 205. G Alonso S, Arancibia L, Givalois 204. SL Bakker T, Heijer den A, Ruitenberg 201. 0.Nghm ,Nbtm ,OiaT Okina Vascular H, Nabatame (2000) Y, Nagahama FH 200. Gage & AR Willhoite TD, Palmer 199. 0.TpaAacbaL aeF iaosL Givalois F, Rage L, Tapia-Arancibia 203. DC Alsop M, Fernandez-Seara Z, Wang 202. 9.Gg H(00 amla erlse cells. stem neural Mammalian (2000) FH Gage 198. 9.FacsS,Ha ,Mri PG Morris K, Head ST, Francis 197. 9.Fse D oodF olnegN 20)Cocoa (2006) NK Hollenberg & FA Sorond ND, Fisher 196. 9.DiQ oesenA,W Y Wu AR, Borenstein Q, Dai 195. , subjectto theCambridgeCore termsofuse,available at http://www.alzheimers-research.org.uk/info/statistics/ BN)i erse ainswt rwtotanti- without or with patients factor depressed neurotrophic brain-derived depressants. in of levels (BDNF) serum of tions DFsrmcnetain nAzemrsdisease. Alzheimer’s in Transm concentrations Neural serum BDNF stress. to sensitivity with the in cells crinology receptors eminence its and median factor neurotrophic brain-derived of n S ocnrtosi lhie’ ies,normal controls. disease, healthy Alzheimer’s Res and in hydrocephalus concentrations pressure CSF and antidepressants. or with 41 depression fibromyalgia without in concentration or serum BDNF Increased in decline cognitive the disease. of Alzheimer’s rate probable progression the of correlates ilg fBN:fcso yohlmcfunction. hypothalamic on focus Neuroendocrinol BDNF: of siology Rot- the dementia: of Study. onset terdam clinical and hypoperfusion bral ih o dl ipcma neurogenesis. hippocampal 425 adult for niche 1433–1438. seseto ucinldvlpeti omlinfant normal MRI. perfusion in 39 labeled spin development arterial using functional brain of Assessment up.2 S215–S220. 2, Suppl. nhatyyugpeople. task young cognitive a healthy to response in fMRI the on cocoa flavanol-rich up.2 S210–S214. 2, Suppl. tbejie n lhie’ ies:teKm Project. Kame the disease: Med Alzheimer’s J Am and juices etable aaosadbanperfusion. brain and flavanols 600–605. , 973–978. , 479–494. , 41 387–394. , 145 119 ilPsychiatry Biol 4737–4747. , n Neurol Ann 751–759. , 113 25 1217–1224. , 77–107. , 57 adoacPharmacol Cardiovasc J 54 789–794. , tal. et adoacPharmacol Cardiovasc J u Neurol Eur 70–75. , tal. et tal. et tal. et tal. et 20)Stage-dependent (2006) 20)Futadveg- and Fruit (2006) tal. et 20)BN serum BDNF (2007) 20)Teefc of effect The (2006) tal. et tal. et tal. et 20)Expression (2004) 50 scit Res Psychiatr J 20)Cerebral (2003) opNeurol Comp J tal. et 20)Altera- (2003) 1–9. , tal. et 20)Cere- (2005) Science 20)Phy- (2004) Neuroimage Psychiatr J (2007) (2008) Endo- Front 287 47 47 J , , ,